<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0602256840
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2018
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        PADO 20MG FILM COATED TABLET
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        PAROXETINE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        31.4
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="UNITED PHARMACEUTICAL COMPANY" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            UNITED PHARMACEUTICAL COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            UNITED PHARMACEUTICAL CO.
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        N06AB05 
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>- Pharmacotherapeutic group: </strong></p><p>- Pado&reg;&nbsp;is one of a group of medicines called SSRIs (selective serotonin reuptake inhibitors). Everyone has a substance called serotonin in their brain. People who are depressed or anxious have lower levels of serotonin than others. It is not fully understood how Pado&reg;&nbsp;and other SSRIs work but they may help by increasing the level of serotonin in the brain. Treating depression or anxiety disorders properly is important to help you get better.</p><p><strong>- Therapeutic indications: </strong></p><p>Pado&reg;<strong>&nbsp;is a treatment for adults with depression and/or anxiety disorders.</strong> The anxiety disorders that Pado&reg;&nbsp;is used to treat are: obsessive compulsive disorder (repetitive, obsessive thoughts with uncontrollable behaviour); panic disorder (panic attacks, including those caused by agoraphobia, which is a fear of open spaces); social anxiety disorder (fear or avoidance of social situations); post-traumatic stress disorder (anxiety caused by a traumatic event); and generalised anxiety disorder (generally feeling very anxious or nervous).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>a. Do not take </strong>Pado&reg;</p><p><strong>&bull; If you are taking medicines called monoamine oxidase inhibitors</strong> (MAOIs, including moclobemide and methylthioninium chloride (methylene blue)) or have taken them at any time within the last two weeks. Your doctor will advise you how you should begin taking Pado&reg;&nbsp; once you have stopped taking the MAOI</p><p><strong>&bull; If you are taking an anti-psychotic</strong> called thioridazine or an antipsychotic called pimozide</p><p><strong>&bull; If you are allergic </strong>to paroxetine or any of the other ingredients of this medicine</p><p><strong>&bull; If any of these apply to you</strong>, tell your doctor without taking Pado&reg;&nbsp;</p><p><strong>b. Take special care with </strong>Pado&reg;<strong>&nbsp;</strong></p><p><strong>Talk to your doctor or pharmacist before taking </strong>Pado&reg;<strong>&nbsp; </strong></p><p>- Are you taking any other medicines.</p><p>- Are you taking tamoxifen to treat breast cancer or fertility problems? Pado&reg;&nbsp;may make tamoxifen less effective, so your doctor may recommend you take another antidepressant.</p><p>- Do you have kidney, liver or heart trouble.</p><p>- Do you have epilepsy or have a history of fits or seizures.</p><p>- Have you ever had episodes of mania (overactive behaviour or thoughts).</p><p>- Are you having electro-convulsive therapy (ECT).</p><p>- Do you have a history of bleeding disorders, or are you taking other medicines that may increase the risk of bleeding (these include medicines used to thin the blood, such as warfarin, anti-psychotics such as perphenazine or clozapine, tricyclic antidepressants, medicines used for pain and inflammation called non-steroidal anti-inflammatory drugs or NSAIDs, such as acetylsalicylic acid, ibuprofen, celecoxib, etodolac, diclofenac, meloxicam).</p><p>- Do you have diabetes.</p><p>- Are you on a low sodium diet.</p><p>- Do you have glaucoma (pressure in the eye).</p><p>- Are you pregnant or planning to get pregnant.</p><p>- Are you under 18 years old.</p><p><strong>If you answer YES to any of these questions, and you have not already discussed them with your doctor, go back to your doctor and ask what to do about taking </strong>Pado&reg;<strong>. </strong></p><p><strong>Children and adolescents under 18 </strong></p><p>Pado&reg;<strong>&nbsp;should not be used for children and adolescents under 18 years.</strong> Also, patients under 18 have an increased risk of side effects such as suicide attempt, suicidal thoughts and hostility (predominantly aggression, oppositional behaviour and anger) when they take Pado&reg;&nbsp;. If your doctor has prescribed Pado&reg;&nbsp;for you (or your child) and you want to discuss this, please go back to your doctor. You should inform your doctor if any of the symptoms listed above develop or worsen when you (or your child) are taking Pado&reg;. Also, the long-term safety effects, concerning growth, maturation and cognitive and behavioural development, of Pado&reg;&nbsp;in this age group have not yet been demonstrated.</p><p>Pado&reg;&nbsp;in under 18, common side effects that affected less than 1 in 10 children/adolescents were: an increase in suicidal thoughts and suicide attempts; deliberately harming themselves; being hostile; aggressive or unfriendly; lack of appetite; shaking; abnormal sweating; hyperactivity (having too much energy); agitation; changing emotions (including crying and changes in mood); and unusual bruising or bleeding (such as nose bleeds).</p><p>In addition, patients under 18 also commonly (affecting 3 less than 1 in 10) experienced stomach ache, feeling nervous and changing emotions (including crying, changes in mood, trying to hurt themselves, thoughts of suicide and attempting suicide).</p><p><strong>Thoughts of suicide and worsening of your depression or anxiety disorder </strong></p><p>If you are depressed and/or have anxiety disorders you can sometimes have thoughts of harming or killing yourself. These may be increased when first starting antidepressants, since these medicines all take time to work, usually about two weeks but sometimes longer.</p><p><strong>You may be more likely to think like this: </strong></p><p>&bull; If you have previously had thoughts about killing or harming yourself.</p><p>&bull; If you are a young adult. An increased risk of suicidal behaviour in adults aged less than 25 years with psychiatric conditions who were treated with an antidepressant.</p><p>If you have thoughts of harming or killing yourself at any time, contact your doctor or go to a hospital straight away.</p><p><strong>You may find it helpful to tell a relative or close friend</strong> that you are depressed or have an anxiety disorder, and ask them to read this leaflet. You might ask them to tell you if they think your depression or anxiety is getting worse, or if they are worried about changes in your behaviour.</p><p><strong>Important side effects seen with </strong>Pado&reg;<strong>&nbsp; </strong></p><p>Some patients who take Pado&reg;&nbsp;develop something called akathisia, where they feel restless and feel like they can&rsquo;t sit or stand still. Other patients develop something called serotonin syndrome, or neuroleptic malignant syndrome, where they have some or all of the following symptoms: feeling very agitated or irritable, feeling confused, feeling restless, feeling hot, sweating, shaking, shivering, hallucinations (strange visions or sounds), muscle stiffness, sudden jerks of the muscles or a fast heartbeat. The severity can increase, leading to loss of consciousness. If you notice any of these symptoms, contact your doctor.</p><p><strong>c. Taking other medicines, herbal or dietary supplements </strong></p><p>Some medicines can affect the way Pado&reg;&nbsp;works, or make it more likely that you&rsquo;ll have side effects. Pado&reg;&nbsp;can also affect the way some other medicines work. These include:</p><p>- Medicines called monoamine oxidase inhibitors (MAOIs, including moclobemide and methylthioninium chloride (methylene blue))</p><p>- Thioridazine or pimozide, which are anti-psychotics</p><p>- Aspirin (acetylsalicylic acid), ibuprofen or other medicines called NSAIDs (non-steroidal anti-inflammatory drugs) like celecoxib, etodolac, diclofenac and meloxicam, used for pain and inflammation</p><p>- Tramadol and pethidine, painkillers</p><p>- Medicines called triptans, such as sumatriptan, used to treat migraine</p><p>- Other antidepressants including other SSRIs, tryptophan and tricyclic antidepressants like clomipramine, nortriptyline and desipramine</p><p>- A dietary supplement called tryptophan</p><p>- Mivacurium and suxamethonium (used in anaesthesia)</p><p>- Medicines such as lithium, risperidone, perphenazine, clozapine (called anti-psychotics) used to treat some psychiatric conditions</p><p>- Fentanyl, used in anaesthesia or to treat chronic pain</p><p>- A combination of fosamprenavir and ritonavir, which is used to treat Human Immunodeficiency Virus (HIV) infection</p><p>- St John&rsquo;s Wort, a herbal remedy for depression</p><p>- Phenobarbital, phenytoin, sodium valproate or carbamazepine, used to treat fits or epilepsy</p><p>- Atomoxetine which is used to treat attention deficit hyperactivity disorder (ADHD)</p><p>- Procyclidine, used to relieve tremor, especially in Parkinson&rsquo;s Disease</p><p>- Warfarin or other medicines (called anticoagulants) used to thin the blood</p><p>- Propafenone, flecainide and medicines used to treat an irregular heartbeat</p><p>- Metoprolol, a beta-blocker used to treat high blood pressure and heart problems</p><p>- Pravastatin, used to treat high cholesterol</p><p>- Rifampicin, used to treat tuberculosis (TB) and leprosy</p><p>- Linezolid, an antibiotic</p><p>- Tamoxifen, which is used to treat breast cancer or fertility problems.</p><p><strong>If you are taking or have recently taken any of the medicines in this list,</strong> and you have not already discussed these with your doctor, go back to your doctor and ask what to do. The dose may need to be changed or you may need to be given another medicine.</p><p><strong>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines,</strong> including medicines obtained without a prescription.</p><p><strong>d. Taking </strong>Pado&reg;<strong>&nbsp;with food and drink </strong></p><p>Do not drink alcohol while you are taking Pado&reg;. Alcohol may make your symptoms or side effects worse. Taking Pado&reg;&nbsp;in the morning with food will reduce the likelihood of you feeling sick (nausea).</p><p><strong>e. Pregnancy and breast-feeding </strong></p><p>If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p><strong>Pregnancy:</strong> In babies whose mothers took Pado&reg;&nbsp;during the first few months of pregnancy, there have been some reports showing an increased risk of birth defects, in particular those affecting the heart. In the general population, about 1 in 100 babies are born with a heart defect. This increased to up to 2 in 100 babies in mothers who took Pado&reg;. You and your doctor may decide that it is better for you to change to another treatment or to gradually stop taking Pado&reg;&nbsp;while you are pregnant. However, depending on your circumstances, your doctor may suggest that it is better for you to keep taking Pado&reg;.</p><p><strong>Make sure your midwife or doctor knows you&rsquo;re taking </strong>Pado&reg;<strong>.</strong> When taken during pregnancy, particularly late pregnancy, medicines like Pado&reg;&nbsp; may increase the risk of a serious condition in babies, called persistent pulmonary hypertension of the newborn (PPHN). In PPHN, the blood pressure in the blood vessels between the baby&rsquo;s heart and the lungs is too high. If you take Pado&reg;&nbsp;during the last 3 months of pregnancy, your newborn baby might also have other conditions, which usually begin during the first 24 hours after birth. Symptoms include:</p><p>- Trouble with breathing</p><p>- A blue-ish skin or being too hot or cold</p><p>- Blue lips</p><p>- Vomiting or not feeding properly</p><p>- Being very tired, not able to sleep or crying a lot</p><p>- Stiff or floppy muscles</p><p>- Tremors, jitters or fits</p><p>- Exaggerated reflexes.</p><p>If your baby has any of these symptoms when it is born, or you are concerned about your baby&rsquo;s health, <strong>contact your doctor or midwife who will be able to advise you. </strong></p><p><strong>Breastfeeding: </strong>Pado&reg;<strong>&nbsp;may get into breast milk in very small amounts. </strong>If you are taking Pado&reg;, go back and talk to your doctor before you start breast-feeding. You and your doctor may decide that you can breast-feed while you are taking Pado&reg;.</p><p><strong>f. Driving and using machines </strong></p><p>Possible side effects of Pado&reg;&nbsp;include dizziness, confusion, feeling sleepy or blurred vision. If you do get these side effects, do not drive or use machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Always take this medicine exactly as your doctor or pharmacist has told you. </strong>Check with your doctor or pharmacist if you are not sure.</p><p>Sometimes you may need to take more than one tablet or half a tablet. This table will show you how many tablets to take.</p><p>&nbsp;The usual doses for different conditions are set out in the table below.</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Category</p></td><td style="vertical-align:top"><p>Starting dose</p></td><td style="vertical-align:top"><p>Recommended daily dose</p></td><td style="vertical-align:top"><p>Maximum daily dose</p></td></tr><tr><td style="vertical-align:top"><p>Depression</p></td><td style="vertical-align:top"><p>20 mg</p></td><td style="vertical-align:top"><p>20 mg</p></td><td style="vertical-align:top"><p>50 mg</p></td></tr><tr><td style="vertical-align:top"><p>Obsessive Compulsive Disorder (obsessions and compulsions)</p></td><td style="vertical-align:top"><p>20 mg</p></td><td style="vertical-align:top"><p>40 mg</p></td><td style="vertical-align:top"><p>60 mg</p></td></tr><tr><td style="vertical-align:top"><p>Panic Disorder (panic attacks)</p></td><td style="vertical-align:top"><p>10 mg</p></td><td style="vertical-align:top"><p>40 mg</p></td><td style="vertical-align:top"><p>60 mg</p></td></tr><tr><td style="vertical-align:top"><p>Social Anxiety Disorder (fear or avoidance of social situations)</p></td><td style="vertical-align:top"><p>20 mg</p></td><td style="vertical-align:top"><p>20 mg</p></td><td style="vertical-align:top"><p>50 mg</p></td></tr><tr><td style="vertical-align:top"><p>Post-Traumatic Stress Disorder</p></td><td style="vertical-align:top"><p>20 mg</p></td><td style="vertical-align:top"><p>20 mg</p></td><td style="vertical-align:top"><p>50 mg</p></td></tr><tr><td style="vertical-align:top"><p>Generalised Anxiety Disorder</p></td><td style="vertical-align:top"><p>20 mg</p></td><td style="vertical-align:top"><p>20 mg</p></td><td style="vertical-align:top"><p>50 mg</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Your doctor will advise you what dose to take when you first start taking </strong>Pado&reg;<strong>.</strong> Most people start to feel better after a couple of weeks. If you don&rsquo;t start to feel better after this time, talk to your doctor, who will advise you. He or she may decide to increase the dose gradually, 10 mg at a time, up to a maximum daily dose.</p><p>Take your tablets in the morning with food.</p><p>Swallow them with a drink of water.</p><p>Do not chew.</p><p>Your doctor will talk to you about how long you will need to keep taking your tablets. This may be for many months or even longer.</p><p><strong>Older people </strong></p><p>The maximum dose for people over 65 is 40 mg per day.</p><p><strong>Patients with liver or kidney disease </strong></p><p>If you have trouble with your liver or kidneys your doctor may decide that you should have a lower dose of Pado&reg;&nbsp;than usual. If you have severe liver or kidney disease the maximum dose is 20 mg per day.</p><p><strong>a. If you take more </strong>Pado&reg;<strong>&nbsp;than you should </strong></p><p><strong>Never take more tablets than your doctor recommends.</strong> If you take too many Pado&reg;&nbsp;tablets (or someone else does), tell your doctor or a hospital straight away. Show them the pack of tablets. Someone who has taken an overdose of Pado&reg;&nbsp;may have any one of the symptoms of the possible side effects, or the following symptoms: fever; uncontrollable tightening of the muscles.</p><p><strong>b. If you forget to take </strong>Pado&reg;<strong>&nbsp;</strong></p><p>Take your medicine at the same time every day.</p><p><strong>If you do forget a dose, and you remember before you go to bed,</strong> take it straight away. Carry on as usual the next day.</p><p>If you only remember during the night, or the next day leave out the missed dose. You may possibly get withdrawal effects, but these should go away after you take your next dose at the usual time.</p><p>Do not take a double dose to make up for a forgotten dose.</p><p><strong>What to do if you are feeling no better </strong></p><p>Pado&reg;<strong>&nbsp;will not relieve your symptoms straight away</strong> - all antidepressants take time to work. Some people will start to feel better within a couple of weeks, but for others it may take a little longer. Some people taking antidepressants feel worse before feeling better. If you don&rsquo;t start to feel better after a couple of weeks, go back to your doctor who will advise you. Your doctor should ask to see you again a couple of weeks after you first start treatment. Tell your doctor if you haven&rsquo;t started to feel better.</p><p><strong>c. If you stop taking </strong>Pado&reg;<strong>&nbsp;</strong></p><p><strong>Do not stop taking </strong>Pado&reg;<strong>&nbsp;until your doctor tells you to. </strong></p><p><strong>When stopping </strong>Pado&reg;<strong>,</strong> your doctor will help you to reduce your dose slowly over a number of weeks or months - this should help reduce the chance of withdrawal effects. One way of doing this is to gradually reduce the dose of Pado&reg;&nbsp;you take by 10 mg a week. Most people find that any symptoms on stopping Pado&reg;&nbsp;are mild and go away on their own within two weeks. For some people, these symptoms may be more severe, or go on for longer.</p><p><strong>If you get withdrawal effects</strong> when you are coming off your tablets your doctor may decide that you should come off them more slowly. If you get severe withdrawal effects when you stop taking Pado&reg;, please see your doctor. He or she may ask you to start taking your tablets again and come off them more slowly.</p><p>If you do get withdrawal effects, you will still be able to stop<strong> </strong>Pado&reg;<strong>. </strong></p><p>Possible withdrawal effects when stopping treatment</p><p>Some withdrawal effects on stopping occur more frequently than others.</p><p><strong>Common side effects, likely to affect up to 1 in 10 people: </strong></p><p>- Feeling dizzy, unsteady or off-balance</p><p>- Feelings like pins and needles, burning sensations and (less commonly) electric shock sensations, including in the head</p><p>- Some patients have developed buzzing, hissing, whistling, ringing or other persistent noise in the ears (tinnitus) when they take Pado&reg;&nbsp;</p><p>- Sleep disturbances (vivid dreams, nightmares, inability to sleep)</p><p>- Feeling anxious</p><p>- Headaches.</p><p><strong>Uncommon side effects, likely to affect up to 1 in every 100 people: </strong></p><p>- Feeling sick (nausea)</p><p>- Sweating (including night sweats)</p><p>- Feeling restless or agitated</p><p>- Tremor (shakiness)</p><p>- Feeling confused or disorientated</p><p>- Diarrhoea (loose stools)</p><p>- Feeling emotional or irritable</p><p>- Visual disturbances</p><p>- Fluttering or pounding heartbeat (palpitations).</p><p><strong>Please see your doctor if you are worried about withdrawal effects when stopping </strong>Pado&reg;<strong>. </strong></p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. Side effects are more likely to happen in the first few weeks of taking Pado&reg;.</p><p><strong>See the doctor if you get any of the following side effects during treatment </strong></p><p>You may need to contact your doctor or go to a hospital straight away.</p><p><strong>Uncommon side effects, likely to affect up to 1 in every 100 people: </strong></p><p>- If you have unusual bruising or bleeding, including vomiting blood or passing blood in your stools, contact your doctor or go to a hospital straight away.</p><p>- If you find that you are not able to pass water, contact your doctor or go to a hospital straight away.</p><p><strong>Rare side effects, likely to affect up to 1 in every 1,000 people: </strong></p><p>- If you experience seizures (fits), contact your doctor or go to a hospital straight away.</p><p>- If you feel restless and feel like you can&rsquo;t sit or stand still, you may have something called akathisia. Increasing your dose of Pado&reg;&nbsp;may make these feelings worse. If you feel like this, contact your doctor.</p><p>- If you feel tired, weak or confused and have achy, stiff or uncoordinated muscles this may be because your blood is low in sodium. If you have these symptoms, contact your doctor.</p><p><strong>Very rare side effects, likely to affect up to 1 in every 10,000 people: </strong></p><p>- Allergic reactions, which may be severe to Pado&reg;.</p><p>- If you develop a red and lumpy skin rash, swelling of the eyelids, face, lips, mouth or tongue, start to itch or have difficulty breathing (shortness of breath) or swallowing and feel weak or lightheaded resulting in collapse or loss of consciousness contact your doctor or go to a hospital straight away.</p><p>- If you have some or all of the following symptoms you may have something called serotonin syndrome. The symptoms include: feeling confused, feeling restless, sweating, shaking, shivering, hallucinations (strange visions or sounds), sudden jerks of the muscles or a fast heartbeat. If you feel like this contact your doctor.</p><p>- Acute glaucoma.&nbsp;</p><p>If your eyes become painful and you develop blurred vision, contact your doctor.</p><p><strong>Frequency unknown </strong></p><p>Some people have had thoughts of harming or killing themselves while taking Pado&reg;&nbsp;or soon after stopping treatment.</p><p><strong>Other possible side effects during treatment </strong></p><p><strong>Very common side effects, likely to affect more than 1 in 10 people: </strong></p><p>- Feeling sick (nausea). Taking your medicine in the morning with food will reduce the chance of this happening.</p><p>- Change in sex drive or sexual function. For example, lack of orgasm and, in men, abnormal erection and ejaculation.</p><p><strong>Common side effects, likely to affect up to 1 in 10 people:</strong></p><p>- Increases in the level of cholesterol in the blood</p><p>- Lack of appetite</p><p>- Not sleeping well (insomnia) or feeling sleepy</p><p>- Abnormal dreams (including nightmares)</p><p>- Feeling dizzy or shaky (tremors)</p><p>- Headache</p><p>- Difficulty in concentrating</p><p>- Feeling agitated</p><p>- Feeling unusually weak</p><p>- Blurred vision</p><p>- Yawning, dry mouth</p><p>- Diarrhoea or constipation</p><p>- Vomiting</p><p>- Weight gain</p><p>- Sweating.</p><p><strong>Uncommon side effects, likely to affect up to 1 in every 100 people: </strong></p><p>- A brief increase in blood pressure, or a brief decrease that may make you feel dizzy or faint when you stand up suddenly</p><p>- A faster than normal heartbeat</p><p>- Lack of movement, stiffness, shaking or abnormal movements in the mouth and tongue</p><p>- Dilated pupils</p><p>- Skin rashes</p><p>- Itching</p><p>- Feeling confused</p><p>- Having hallucinations (strange visions or sounds)</p><p>- An inability to urinate (urinary retention) or an uncontrollable, involuntary passing of urine (urinary incontinence)</p><p>- If you are a diabetic patient you may notice a loss of control of your blood sugar levels whilst taking Pado&reg;. Please speak to your doctor about adjusting the dosage of your insulin or diabetes medications.</p><p><strong>Rare side effects, likely to affect up to 1 in every 1,000 people: </strong></p><p>- Abnormal production of breast milk in men and women</p><p>- A slow heartbeat</p><p>- Effects on the liver showing up in blood tests of your liver function</p><p>- Panic attacks</p><p>- Overactive behaviour or thoughts (mania)</p><p>- Feeling detached from yourself (depersonalisation)</p><p>- Feeling anxious</p><p>- Irresistible urge to move the legs (Restless Legs Syndrome)</p><p>- Pain in the joints or muscles</p><p>- Increase in a hormone called prolactin in the blood</p><p>- Menstrual period disorders (including heavy or irregular periods, bleeding between periods and absence or delay of periods</p><p><strong>Very rare side effects, likely to affect up to 1 in every 10,000 people: </strong></p><p>- Skin rash, which may blister, and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge) called erythema multiforme</p><p>- A widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (Stevens-Johnson syndrome)</p><p>- A widespread rash with blisters and skin peeling on much of the body surface (toxic epidermal necrolysis)</p><p>- Liver problems that make the skin or whites of the eyes go yellow</p><p>- Syndrome of inappropriate antidiuretic hormone production (SIADH) which is a condition in which the body develops an excess of water and a decrease in sodium (salt) concentration, as a result of improper chemical signals. Patients with SIADH may become severely ill or may have no symptoms at all</p><p>- Fluid or water retention (which may cause swelling of the arms or legs)</p><p>- Sensitivity to sunlight</p><p>- Painful erection of the penis that won&rsquo;t go away</p><p>- Low blood platelet count.</p><p>- Some patients have developed buzzing, hissing, whistling, ringing or other persistent noise in the ears (tinnitus) when they take Pado&reg;.</p><p>- An increased risk of bone fractures has been observed in patients taking this type of medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- Keep out of the reach and sight of children.</p><p>- Store below 30&deg;C, in a dry place.</p><p>- Do not use Pado&reg;&nbsp;after the expiry date (Exp. Date) which is stated on the outer pack. The expiry date refers to the last day of that month.</p><p>- Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull;&nbsp; The active substance is: Paroxetine.</p><p>Pado&reg;&nbsp;<strong>20</strong>: Each film coated tablet contains Paroxetine Hydrochloride equivalent to 20 mg Paroxetine.</p><p>&bull; The other ingredients are: Calcium hydrogen phosphate, Sodium Starch Glycolate, Magnesium stearate &amp; Opadry White OY-L-28900.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                - Film coated tablet 
- Physical Description: Oval-shaped white biconvex film coated tablet, scored at one side and embossed with “I 77” on other side.
- Pado® 20 is packed in white opaque PVC/ PVDC/ Aluminum foil blister, in carton box with a multi folded leaflet.
- Pack size: Pado® 20 is available in the pack size of 30 F.C. tablets (10 tablets/blister, 3 blisters/ pack).
Hospital packs are also available.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The United Pharmaceutical Mfg. Co. Ltd.</p><p>P.O. Box 69, Amman 11591-Jordan</p><p>Tel: + 962 (6) 416 2901&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>Fax: + 962 (6) 416 2905</p><p>E-mail:&nbsp; info@upm.com.jo</p><p>For any information about this medicinal product, please contact the local representative of the Marketing Authorization Holder:</p><p>Cigalah Group</p><p>P.O. Box 19435, Jeddah 21435 -KSA</p><p>Tel: +966126136740&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>Fax: + 96626148458</p><p>E-mail:info.reg@cigalah.com.sa</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last approved in 04 / 2020 ; version number M3-14-1304
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>- </strong><strong>المجموعة</strong><strong> </strong><strong>الدوائية</strong><strong>: </strong></p><p dir="RTL">يعتبر <strong>بادو</strong>&nbsp; واحد من مجموعة الأدوية والتي تسمى اس اس اراي (مثبطات اعادة امتصاص السيروتونين الانتقائية). كل شخص يمتلك مادة تسمى السيروتونين في الدماغ. إن الاشخاص المصابون بالاكتئاب أو القلق لديهم مستويات منخفضة من السيروتونين عن غيرهم من الاشخاص. ليس مفهوماً تماماً كيفية عمل <strong>بادو</strong>&nbsp; ومثبطات اعادة امتصاص السيروتونين الانتقائية الأخرى لكنها قد تساعد من خلال زيادة مستوى السيروتونين في الدماغ. إن علاج الاكتئاب أو اضطرابات القلق بشكل صحيح مهم وذلك لمساعدتك لتكون أفضل.</p><p dir="RTL"><strong>- </strong><strong>الاستعمالات</strong><strong> </strong><strong>العلاجية</strong><strong>: </strong></p><p><strong>يستعمل بادو&nbsp; لعلاج للبالغين الذين يعانون من اضطرابات الاكتئاب و / أو القلق.</strong> ان اضطرابات القلق التي يستعمل <strong>بادو</strong>&nbsp; لعلاجها هي: اضطراب الوسواس القهري (المتكرر، أفكار وسواسية مع سلوك لا يمكن السيطرة عليه)؛ اضطراب الهلع (نوبات الذعر، بما في ذلك تلك الناجمة عن الخوف من الأماكن المكشوفة، وهو الخوف من الأماكن المفتوحة)؛ اضطراب القلق الاجتماعي (الخوف أو تجنب المواقف الاجتماعية)؛ اضطراب ما بعد الصدمة (القلق الناجم عن حدث أليم)؛ واضطراب القلق العام (شعور عام بالقلق&nbsp; أو العصبية</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>أ</strong><strong>. </strong><strong>لا</strong><strong> </strong><strong>تأخذ</strong><strong> </strong><strong>بادو</strong><strong>&nbsp; </strong></p><p dir="RTL">&bull;<strong> </strong><strong>إذا</strong><strong> </strong><strong>كنت</strong><strong> </strong><strong>تتناول</strong><strong> </strong><strong>أدوية</strong><strong> </strong><strong>تسمى</strong><strong> </strong><strong>مثبطات</strong><strong> </strong><strong>مونوأمين</strong><strong> </strong><strong>أوكسيديز</strong> (MAOIs، بما في ذلك موكلوبميد وكلوريد الميثيل ثايونينيوم (الميثيلين الأزرق)) أو تناولتها في أي وقت خلال الأسبوعين الماضيين. طبيبك سوف ينصحك كيف يجب أن تبدأ في تناول <strong>بادو</strong>&nbsp; عند توقفك عن تناول MAOI</p><p dir="RTL">&bull; <strong>إذا</strong><strong> </strong><strong>كنت</strong><strong> </strong><strong>تتناول</strong><strong> </strong><strong>مضادة</strong><strong> </strong><strong>للذهان</strong> يسمى ثيوريدازين أو مضادة للذهان يسمى بيموزيد</p><p dir="RTL">&bull; <strong>إذا</strong><strong> </strong><strong>كان</strong><strong> </strong><strong>لديك</strong><strong> </strong><strong>حساسية</strong> من مادة الباروكستين أو لأي من المكونات الأخرى في هذا الدواء</p><p dir="RTL">&bull;<strong> </strong><strong>إذا</strong><strong> </strong><strong>كان</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>من</strong><strong> </strong><strong>هذه</strong><strong> </strong><strong>ينطبق</strong><strong> </strong><strong>عليك</strong>، أخبر طبيبك ولا تتناول <strong>بادو</strong></p><p dir="RTL"><strong>ب</strong><strong>. </strong><strong>الاحتياطات</strong><strong> </strong><strong>عند</strong><strong> </strong><strong>استعمال</strong><strong> </strong><strong>بادو</strong><strong>&nbsp; </strong></p><p dir="RTL">تحدث مع طبيبك أو الصيدلاني قبل تناول <strong>بادو</strong></p><p dir="RTL">- هل تتناول أي أدوية أخرى؟</p><p dir="RTL">- هل تناول عقار تاموكسيفين لعلاج سرطان الثدي أو مشاكل الخصوبة؟ قد يجعل <strong>بادو</strong>&nbsp; تاموكسيفين أقل فعالية، لذلك قد يوصي طبيبك بتناول مضاد للاكتئاب أخر.</p><p dir="RTL">- هل لديك مشاكل في الكلى والكبد أو في القلب</p><p dir="RTL">- هل لديك صرع أو لديك تاريخ مسبق للاصابة نوبات أو تشنجات</p><p dir="RTL">- هل سبق وكان لديك نوبات من الهوس (سلوك مفرط أو أفكار)</p><p dir="RTL">- هل تخضع للعلاج الكهربائي للسيطرة على النوبات</p><p dir="RTL">- هل لديك تاريخ لحدوث اضطرابات نزفية، أو هل تتناول أدوية أخرى قد تزيد من خطر النزيف (وتشمل هذه الأدوية التي تستعمل لترقيق الدم، مثل الوارفارين، مضادات الذهان مثل بيرفينازين أو كلوزابين، ومضادات الاكتئاب ثلاثية الحلقات، الأدوية التي تستعمل لعلاج الآلام والالتهاب وتسمى العقاقير المضادة للالتهاب غير الستيرويدية، مثل حمض اسيتيل ساليساليك، ايبوبروفين، سيليكوكسيب، ايتودولاك، ديكلوفيناك، ميلوكسيكام)</p><p dir="RTL">- هل لديك مرض السكري</p><p dir="RTL">- هل تتبع نظام غذائي منخفض الصوديوم</p><p dir="RTL">- هل تعاني من الزرق (ارتفاع ضغط العين)</p><p dir="RTL">- هل أنت حامل أو تخططين للحصول على الحمل</p><p dir="RTL">- هل أنت أقل من 18 عاما</p><p dir="RTL"><strong>إذا</strong><strong> </strong><strong>أجبت</strong><strong> </strong><strong>بنعم</strong><strong> </strong><strong>على</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>من</strong><strong> </strong><strong>هذه</strong><strong> </strong><strong>الأسئلة،</strong><strong> </strong><strong>و</strong><strong> </strong><strong>لم</strong><strong> </strong><strong>تكن</strong><strong> </strong><strong>قد</strong><strong> </strong><strong>ناقشتها</strong><strong> </strong><strong>مع</strong><strong> </strong><strong>طبيبك،</strong><strong> </strong><strong>يجب</strong><strong> </strong><strong>عليك</strong><strong> </strong><strong>العودة</strong><strong> </strong><strong>إلى</strong><strong> </strong><strong>الطبيب</strong><strong> </strong><strong>وسؤاله</strong><strong> </strong><strong>على</strong><strong> </strong><strong>ما</strong><strong> </strong><strong>يجب</strong><strong> </strong><strong>فعله</strong><strong> </strong><strong>حيال</strong><strong> </strong><strong>تناول</strong> <strong>بادو</strong> .</p><p dir="RTL"><strong>الأطفال</strong><strong> </strong><strong>والمراهقين</strong><strong> </strong><strong>دون</strong><strong> </strong><strong>سن</strong><strong> 18 </strong><strong>عاما</strong></p><p dir="RTL"><strong>يجب</strong><strong> </strong><strong>عدم</strong><strong> </strong><strong>استعمال</strong> <strong>بادو</strong> <strong>&nbsp;</strong><strong>في</strong><strong> </strong><strong>الأطفال</strong><strong> </strong><strong>والمراهقين</strong><strong> </strong><strong>دون</strong><strong> </strong><strong>سن</strong><strong> 18 </strong><strong>عاما</strong><strong>.</strong> أيضا، فان المرضى الذين تقل أعمارهم عن 18 عرضة لخطر متزايد لحدوث آثار جانبية مثل محاولة الانتحار، وأفكار انتحارية والعداء (في الغالب العدوان، وسلوك المعارضة والغضب) عند تناول <strong>بادو</strong> . إذا بدء طبيبك في استعمال <strong>بادو</strong>&nbsp; لك (أو لطفلك)، وترغب في مناقشة هذا الموضوع، يرجى العودة إلى الطبيب. يجب إبلاغ الطبيب إذا تطورت لديك (أو طفلك) أي من الأعراض المذكورة أعلاه أو ازدادت سوءا عند&nbsp; تناول <strong>بادو</strong> . أيضا، لم يثبت بعد مدى السلامة على المدى الطويل، فيما يتعلق بالنمو، والنضج والتطور المعرفي والسلوكي، عند استعمال <strong>بادو</strong>&nbsp; في هذه الفئة العمرية.</p><p dir="RTL">كانت الآثار الجانبية الشائعة التي أثرت على أقل من 1 في 10 الأطفال / المراهقين عند استعمال <strong>بادو</strong> &nbsp;في الفئة الأقل من 18عاما: زيادة في الأفكار الانتحارية ومحاولات الانتحار. إيذاء أنفسهم عمدا. العداء في طبيعتهم. عدوانية أو غير ودية. نقص الشهية؛ الهز؛ التعرق غير الطبيعي. فرط النشاط (وجود الكثير من الطاقة)؛ الإثارة. تغيير المشاعر (بما في ذلك البكاء وتغيرات في المزاج)؛ وكدمات أو نزيف غير عادي (مثل نزيف الأنف).</p><p dir="RTL">وبالإضافة إلى ذلك، فان المرضى تحت سن 18 عاما يعانون عادة (يؤثر على 3 أقل من 1 في 10) من آلام المعدة، الشعور بالتوتر وتغيير المشاعر (بما في ذلك البكاء، تغيرات في المزاج، محاولة لإيذاء أنفسهم، التفكير في الانتحار ومحاولة الانتحار) أيضا.</p><p dir="RTL"><strong>التفكير</strong><strong> </strong><strong>في</strong><strong> </strong><strong>الانتحار</strong><strong> </strong><strong>وتفاقم</strong><strong> </strong><strong>بك</strong><strong> </strong><strong>الاكتئاب</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>اضطرابات</strong><strong> </strong><strong>القلق</strong></p><p dir="RTL">إذا كنت مكتئبا و / أو تعاني من اضطرابات القلق يمكن أن تعاني في بعض الأحيان من أفكار إيذاء أو قتل نفسك. يمكن أن تزداد هذه عند بداية العالج باستعمال مضادات الاكتئاب لأول مرة ، لأن هذه الأدوية قد تستغرق وقتا طويلا للعمل، عادة حوالي أسبوعين لكن في بعض الأحيان لفترة أطول.</p><p dir="RTL"><strong>قد</strong><strong> </strong><strong>تكون</strong><strong> </strong><strong>أكثر</strong><strong> </strong><strong>عرضة</strong><strong> </strong><strong>للتفكير</strong><strong> </strong><strong>بمثل</strong><strong> </strong><strong>هذه</strong><strong> </strong><strong>إذا</strong><strong>:</strong></p><p dir="RTL">&bull; إذا كنت تعاني مسبقا من أفكار حول قتل أو إيذاء نفسك.</p><p dir="RTL">&bull; إذا كنت من الشباب البالغين. هناك زيادة خطر السلوك الانتحاري لدى البالغين الذين تقل أعمارهم عن 25 عاما مع وجود ظروف نفسية والذين عولجوا مع مضاد للاكتئاب.</p><p dir="RTL">إذا كان لديك أفكار إيذاء أو قتل نفسك في أي وقت، اتصل بطبيبك أو اذهب إلى المستشفى على الفور.</p><p dir="RTL"><strong>قد</strong><strong> </strong><strong>تجد</strong><strong> </strong><strong>أنه</strong><strong> </strong><strong>من</strong><strong> </strong><strong>المفيد</strong><strong> </strong><strong>إخبار</strong><strong> </strong><strong>صديق</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>قريب</strong> اذا كنت مكتئبا أو تعاني من اضطرابات القلق، وتطلب منه أن يقرأ هذه النشرة. قد تطلب منهم ان يخبروك اذا كانوا يعتقدون بأن الاكتئاب أو القلق قد زاد سوءا، أو إذا كانوا قلقين بشأن التغيرات في السلوك الخاص بك.</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>هامة</strong><strong> </strong><strong>تمت</strong><strong> </strong><strong>ملاحظتها</strong><strong> </strong><strong>مع</strong><strong> </strong><strong>بادو</strong><strong> </strong></p><p dir="RTL">بعض المرضى الذين يتناولون <strong>بادو</strong>&nbsp; تطور لديهم ما يسمى بالتململ، حيث أنهم يشعرون بعدم الراحة ويشعرون أنهم لا يستطيعون الجلوس أو الوقوف دون حراك. تطور عند مرضى آخرين ما يسمى بمتلازمة السيروتونين، أو متلازمة الذهان الخبيثة، حيث لديهم بعض أو كل الأعراض التالية: الشعور بالهياج أو سرعة الانفعال، الشعور بالخلط، الشعور بضيق الصدر، الشعور بالسخونة، التعرق، والهز، والارتعاش، هلوسة (رؤية أو أصوات غريبة)، تصلب العضلات، الهزات المفاجئة للعضلات أو سرعة ضربات القلب. يمكن أن تزيد شدة هذه الاعراض، مما يؤدي إلى فقدان الوعي. إذا لاحظت أي من هذه الأعراض، اتصل بطبيبك فورا.</p><p dir="RTL"><strong>ج</strong><strong>. </strong><strong>التداخلات</strong><strong> </strong><strong>الدوائية</strong><strong> </strong><strong>من</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>هذا</strong><strong> </strong><strong>المستحضر</strong><strong> </strong><strong>مع</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>أدوية</strong><strong> </strong><strong>أخرى</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>أعشاب</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>مكملات</strong><strong> </strong><strong>غذائية</strong></p><p dir="RTL">يمكن لبعض الأدوية أن تؤثر على الطريقة التي يعمل بها <strong>بادو</strong> ، أو تجعلك أكثر عرضة للاصابة بآثار جانبية. يمكن أن يؤثر <strong>بادو</strong> أيضا على الطريقة التي تعمل بها بعض الأدوية الأخرى. وتشمل هذه:</p><p dir="RTL">- الأدوية التي تسمى مثبطات مونو أمين أوكسيديز (MAOIs، بما في ذلك موكلوبميد وكلوريد الميثيل ثايونينيوم (الميثيلين الأزرق))</p><p dir="RTL">- الثيوريدازين أو بيموزيد، والتي هي مضادات للذهان</p><p dir="RTL">- الأسبرين (حمض اسيتيل ساليساليك)، ايبوبروفين أو غيرها من الأدوية التي تسمى مضادات الالتهاب غير الستيرويدية مثل سيليكوكسيب، ايتودولاك، ديكلوفيناك وميلوكسيكام، وتستعمل لعلاج الآلام والالتهاب</p><p dir="RTL">- ترامادول وبيثيدين، مسكنات الألم</p><p dir="RTL">- الأدوية التي تسمى تريبتان، مثل سوماتريبتان، وتستعمل لعلاج الصداع النصفي</p><p dir="RTL">- مضادات الاكتئاب الأخرى بما في ذلك مثبطات اعادة امتصاص السيروتونين الانتقائية الأخرى، تريبتوفان، ومضادات الاكتئاب ثلاثية الحلقات مثل كلوميبرامين، نورتريبتيلين وديسيبرامين</p><p dir="RTL">- من المكملات الغذائية والتي تسمى تربتوفان</p><p dir="RTL">- ميفاكوريوم وساكساميثونيوم (التي تستعمل في التخدير)</p><p dir="RTL">- الأدوية مثل الليثيوم، ريسبيريدون، بيرفينازين، كلوزابين (وتسمى مضادات الذهان) وتستعمل لعلاج بعض الحالات النفسية</p><p dir="RTL">- الفنتانيل، وتستعمل في التخدير أو لعلاج الألم المزمن</p><p dir="RTL">- مزيج من فوسامبرينافيروريتونافير، والتي تستعمل لعلاج عدوى فيروس نقص المناعة المكتسبة البشري (HIV)</p><p dir="RTL">- نبتة سانت جون، نبتة عشبية لعلاج الاكتئاب</p><p dir="RTL">- فينوباربيتال، فينيتوين، فالبروات الصوديوم أو كاربامازيبين، وتستعمل لعلاج النوبات أو الصرع</p><p dir="RTL">- اتومكيسيتين الذي يستعمل لعلاج اضطراب نقص الانتباه وفرط الحركة (ADHD)</p><p dir="RTL">- بروسيكليدين، وتستعمل لتخفيف الهزة، وخاصة في مرض باركنسون</p><p dir="RTL">- وارفارين أو أدوية أخرى (تسمى مضادات التخثر) تستعمل لتميع الدم</p><p dir="RTL">- بروبافينون، فليكينايد والأدوية المستعملة لعلاج عدم انتظام ضربات القلب</p><p dir="RTL">- ميتوبرولول، من حاصرات مستقبلات بيتا المستعملة في علاج الضغط المرتفع ومشاكل القلب</p><p dir="RTL">- برافاستاتين، وتستعمل لعلاج ارتفاع الكوليسترول في الدم</p><p dir="RTL">- ريفامبيسين، وتستعمل لعلاج السل (TB) والجذام</p><p dir="RTL">- لينزولايد، مضاد حيوي</p><p dir="RTL">- تاموكسيفين، والذي يستعمل لعلاج سرطان الثدي أو مشاكل الخصوبة.</p><p dir="RTL"><strong>إذا</strong><strong> </strong><strong>كنت</strong><strong> </strong><strong>تتناول</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>تناولت</strong><strong> </strong><strong>مؤخرا</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>من</strong><strong> </strong><strong>الأدوية</strong><strong> </strong><strong>في</strong><strong> </strong><strong>هذه</strong><strong> </strong><strong>القائمة</strong>، واذا لم تكن قد تناقشت مع طبيبك، يجب العودة إلى الطبيب وسؤاله عما يجب القيام به. قد تحتاج إلى تغيير الجرعة أو قد تحتاج إلى تناول دواء آخر.</p><p dir="RTL"><strong>أخبر</strong><strong> </strong><strong>طبيبك</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>الصيدلاني</strong><strong> </strong><strong>إذا</strong><strong> </strong><strong>كنت</strong><strong> </strong><strong>تتناول،</strong><strong> </strong><strong>قد</strong><strong> </strong><strong>تناولت</strong><strong> </strong><strong>مؤخرا</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>قد</strong><strong> </strong><strong>تتناول</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>أدوية</strong><strong> </strong><strong>أخرى،</strong> بما في ذلك الأدوية التي تم الحصول عليها دون وصفة طبية.</p><p dir="RTL"><strong>د</strong><strong>. </strong><strong>تناول</strong><strong> </strong><strong>بادو</strong><strong>&nbsp; </strong><strong>مع</strong><strong> </strong><strong>الطعام</strong><strong> </strong><strong>والشراب</strong></p><p dir="RTL">لا تشرب الكحول بينما تأخذ <strong>بادو</strong> . قد يجعل الكحول الأعراض الخاصة بك أو آثار جانبية أسوأ. تناول <strong>بادو</strong>&nbsp; في الصباح مع الطعام يقلل من احتمالات الشعور بالغثيان.</p><p dir="RTL"><strong>هـ</strong><strong>. </strong><strong>الحمل</strong><strong> </strong><strong>والرضاعة</strong><strong> </strong></p><p dir="RTL">إذا كنت حاملا أو ترضعين رضاعة طبيعية، تعتقدين بأنك قد تكون حاملا أو تخططين لإنجاب طفل، اسألي طبيبك أو الصيدلاني للحصول على المشورة قبل تناول هذا الدواء.</p><p dir="RTL"><strong>الحمل</strong><strong>:</strong> في الأطفال الرضع الذين تناولت أمهاتهم <strong>بادو</strong>&nbsp; خلال الأشهر الأولى من الحمل، كانت هناك بعض التقارير التي تبين زيادة خطر حدوث التشوهات الخلقية، ولا سيما تلك التي تؤثر على القلب. في عموم السكان، يولد حوالي 1 في كل 100 طفل مع تشوهات في القلب. تزداد هذه لتصل إلى 2 في كل 100 طفل لأمهات تناولن <strong>بادو</strong> . يستطيع الطبيب ان يقرر الأفضل بالنسبة لك إما التغيير إلى علاج آخر أو وقف تناول <strong>بادو</strong>&nbsp; بشكل&nbsp; تدريجي اذا كنت حاملا. ومع ذلك، هذا يتوقف على الظروف الخاصة بك، قد يقترح الطبيب أنه من الأفضل لك أن تستمري في أخذ <strong>بادو</strong> .</p><p dir="RTL"><strong>تأكدي</strong><strong> </strong><strong>بأن</strong><strong>&nbsp; </strong><strong>طبيبك</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>ممرضة</strong><strong> </strong><strong>التوليد</strong><strong> </strong><strong>يعرفون</strong><strong> </strong><strong>بأنك</strong><strong> </strong><strong>كنت</strong><strong> </strong><strong>تتناولين</strong> <strong>بادو</strong> . عندما يؤخذ خلال فترة الحمل، وخاصة في المرحلة المتأخرة من الحمل، قد تزيد الأدوية مثل <strong>بادو</strong>&nbsp; من خطر حدوث حالة خطيرة في الأطفال، تسمى ارتفاع ضغط الدم الرئوي المستمر لحديثي الولادة (PPHN). في ارتفاع ضغط الدم الرئوي المستمر لحديثي الولادة، يكون ضغط الدم في الأوعية الدموية بين قلب الطفل والرئتين مرتفع جدا. إذا كنت تتناولين <strong>بادو</strong>&nbsp; خلال 3 أشهر الأخيرة من الحمل، قد يعاني الطفل الرضيع حديث الولادة أيضا من اثار أخرى، والتي تبدأ عادة خلال الـ 24 ساعة الأولى بعد الولادة. وتشمل الأعراض:</p><p dir="RTL">- صعوبة في التنفس</p><p dir="RTL">- جلد أزرق أو الشعور بالحر أو البرودة</p><p dir="RTL">- الشفاه الزرقاء</p><p dir="RTL">- القيء أو عدم التغذية بشكل صحيح</p><p dir="RTL">- أن تكون متعبا للغاية، ولست قادرا على النوم أو البكاء كثير</p><p dir="RTL">- تصلب العضلات أو مرونتها</p><p dir="RTL">- الهزات، التوتر أو النوبات</p><p dir="RTL">- ردود الفعل المبالغ فيها.</p><p dir="RTL">إذا كان طفلك لديه أي من هذه الأعراض عند ولادته، أو كنت قلقة بشأن صحة طفلك، <strong>اتصل</strong><strong> </strong><strong>بطبيبك</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>ممرضة</strong><strong> </strong><strong>التوليد</strong><strong> </strong><strong>الذي</strong><strong> </strong><strong>سيكون</strong><strong> </strong><strong>قادرا</strong><strong> </strong><strong>على</strong><strong> </strong><strong>تقديم</strong><strong> </strong><strong>النصح</strong><strong> </strong><strong>لك</strong><strong>.</strong></p><p dir="RTL"><strong>الرضاعة</strong><strong> </strong><strong>الطبيعية</strong><strong>: </strong><strong>قد</strong><strong> </strong><strong>يفرز</strong><strong> </strong><strong>بادو</strong><strong>&nbsp; </strong><strong>في</strong><strong> </strong><strong>حليب</strong><strong> </strong><strong>الثدي</strong><strong> </strong><strong>بكميات</strong><strong> </strong><strong>صغيرة</strong><strong> </strong><strong>جدا</strong><strong>.</strong> إذا كنت تتناول <strong>بادو</strong> ، يجب العودة والتحدث مع طبيبك قبل البدء في الرضاعة الطبيعية. يتطيع والطبيب أن يقرر اذا بامكانك الرضاعة وانت تتناولين <strong>بادو</strong> .</p><p dir="RTL"><strong>و</strong><strong>. </strong><strong>القيادة</strong><strong> </strong><strong>واستعمال</strong><strong> </strong><strong>الآلات</strong></p><p dir="RTL">تشمل الآثار الجانبية المحتملة مع استعمال <strong>بادو</strong>&nbsp; دوخة، الارتباك، والشعور بالنعاس أو عدم وضوح الرؤية. إذا حدثت هذه الآثار الجانبية، لا تقد السيارة أو تستعمل الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>دائما</strong><strong> </strong><strong>تتناول</strong><strong> </strong><strong>هذا</strong><strong> </strong><strong>الدواء</strong><strong> </strong><strong>تماما</strong><strong> </strong><strong>كما</strong><strong> </strong><strong>أخبرك</strong><strong> </strong><strong>طبيبك</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>الصيدلاني</strong><strong>.</strong> استشر طبيبك أو الصيدلاني إذا لم تكن متأكدا.</p><p dir="RTL">في بعض الأحيان قد تحتاج إلى تناول قرص أكثر من واحد أو نصف قرص. وهذا الجدول يبين لك كم قرص يجب ان تتناول.</p><p dir="RTL">تم تعيين الجرعات الاعتيادية لحالات مختلفة في الجدول أدناه.</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL">الفئة</p></td><td style="vertical-align:top"><p dir="RTL">الجرعة الابتدائية</p></td><td style="vertical-align:top"><p dir="RTL">الجرعة اليومية الموصى بها</p></td><td style="vertical-align:top"><p dir="RTL">الجرعة اليومية القصوى</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">الاكتئاب</p></td><td style="vertical-align:top"><p dir="RTL">&nbsp;20 ملغم</p></td><td style="vertical-align:top"><p dir="RTL">20 ملغم</p></td><td style="vertical-align:top"><p dir="RTL">50 ملغم</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">اضطراب الوسواس القهري (الوسواس والأفعال القهرية)</p></td><td style="vertical-align:top"><p dir="RTL">20 ملغم</p></td><td style="vertical-align:top"><p dir="RTL">40 ملغم</p></td><td style="vertical-align:top"><p dir="RTL">60 ملغم</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">اضطراب الهلع (نوبات الذعر)</p></td><td style="vertical-align:top"><p dir="RTL">10 ملغم</p></td><td style="vertical-align:top"><p dir="RTL">40 ملغم</p></td><td style="vertical-align:top"><p dir="RTL">60 ملغم</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">اضطراب القلق الاجتماعي (الخوف أو تجنب المواقف الاجتماعية)</p></td><td style="vertical-align:top"><p dir="RTL">20 ملغم</p></td><td style="vertical-align:top"><p dir="RTL">20 ملغم</p></td><td style="vertical-align:top"><p dir="RTL">50 ملغم</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">اضطراب ما بعد الصدمة</p></td><td style="vertical-align:top"><p dir="RTL">20 ملغم</p></td><td style="vertical-align:top"><p dir="RTL">20 ملغم</p></td><td style="vertical-align:top"><p dir="RTL">50 ملغم</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">اضطراب القلق المعمم</p></td><td style="vertical-align:top"><p dir="RTL">20 ملغم</p></td><td style="vertical-align:top"><p dir="RTL">20 ملغم</p></td><td style="vertical-align:top"><p dir="RTL">50 ملغم</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>سوف</strong><strong> </strong><strong>ينصحك</strong><strong> </strong><strong>طبيبك</strong><strong> </strong><strong>بالجرعة</strong><strong> </strong><strong>التي</strong><strong> </strong><strong>يجب</strong><strong> </strong><strong>تناولها</strong><strong> </strong><strong>عند</strong><strong> </strong><strong>بدء</strong><strong> </strong><strong>تناول</strong> <strong>بادو</strong> . يبدأ معظم الناس الشعور بتحسن بعد بضعة أسابيع. إذا كنت لم تبدأ في الشعور بالتحسن بعد هذا الوقت، يجب التحدث إلى طبيبك الذي سوف يقدم النصح لك. يجوز له أن يقرر زيادة الجرعة تدريجيا، 10 ملغم في كل مرة، للوصول لجرعة يومية قصوى.</p><p dir="RTL">تناول الأقراص في الصباح مع الطعام.</p><p dir="RTL">ابلعه مع شربة ماء.</p><p dir="RTL">لا تمضعه.</p><p dir="RTL">طبيبك سوف يحدثك عن المدة التي سوف تحتاجها للمحافظة على تناول الأقراص. قد يكون هذا لعدة أشهر أو حتى لفترة أطول.</p><p dir="RTL"><strong>كبار</strong><strong> </strong><strong>السن</strong></p><p dir="RTL">تبلغ الجرعة القصوى للمرضى الاكبر&nbsp; من 65 عاما 40 ملغم يوميا.</p><p dir="RTL"><strong>المرضى</strong><strong> </strong><strong>الذين</strong><strong> </strong><strong>يعانون</strong><strong> </strong><strong>من</strong><strong> </strong><strong>أمراض</strong><strong> </strong><strong>الكبد</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>الكلى</strong></p><p dir="RTL">إذا كان لديك مشكلة مع الكبد أو الكليتين، فان طبيبك سيقرر اذا ما كان بحاجة لجرعة أقل من المعتاد من <strong>بادو</strong> . إذا كان لديك مرض حاد في الكبد أو الكلى فان الجرعة القصوى هي 20 ملغم يوميا.</p><p dir="RTL"><strong>أ</strong><strong>. </strong><strong>إذا</strong><strong> </strong><strong>تناولت</strong><strong> </strong><strong>بادو</strong><strong>&nbsp; </strong><strong>أكثر</strong><strong> </strong><strong>مما</strong><strong> </strong><strong>يجب</strong></p><p dir="RTL"><strong>لا</strong><strong> </strong><strong>تتناول</strong><strong> </strong><strong>أكثر</strong><strong> </strong><strong>من</strong><strong> </strong><strong>كمية</strong><strong> </strong><strong>الأقراص</strong><strong> </strong><strong>التي</strong><strong> </strong><strong>اوصى</strong><strong> </strong><strong>بها</strong><strong> </strong><strong>طبيبك</strong><strong>.</strong> إذا كنت تناولت الكثير من أقراص <strong>بادو</strong>&nbsp; (أو أي شخص آخر)، أخبر طبيبك أو المستشفى على الفور. أظهر لهم عبوة الأقراص. الشخص الذي تناول جرعة زائدة من <strong>بادو</strong>&nbsp; قد يعاني أعراض من الآثار الجانبية المحتملة، أو الأعراض التالية: حمى؛ صلابة في العضلات لا يمكن السيطرة عليها.</p><p dir="RTL"><strong>ب</strong><strong>. </strong><strong>إذا</strong><strong> </strong><strong>نسيت</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>بادو</strong><strong>&nbsp; </strong></p><p dir="RTL">تناول الدواء في نفس الوقت كل يوم.</p><p dir="RTL"><strong>إذا</strong><strong> </strong><strong>كنت</strong><strong> </strong><strong>نسيت</strong><strong> </strong><strong>الجرعة،</strong><strong> </strong><strong>وتذكرتها</strong><strong> </strong><strong>قبل</strong><strong> </strong><strong>أن</strong><strong> </strong><strong>الذهاب</strong><strong> </strong><strong>إلى</strong><strong> </strong><strong>السرير،</strong> تناولها على الفور. استمر في تناول العلاج كالمعتاد في اليوم التالي.</p><p dir="RTL">إذا تذكرت الجرعة المنسية فقط أثناء الليل، أو في اليوم التالي اترك الجرعة المنسية. قد تحصل آثار الانسحاب، ولكن هذه الاعراض قد تزول بعد تناول الجرعة التالية في الوقت المعتاد.</p><p dir="RTL">لا تتناول جرعة مضاعفة لتعويض الجرعة المنسية.</p><p dir="RTL"><strong>ماذا</strong><strong> </strong><strong>تفعل</strong><strong> </strong><strong>إذا</strong><strong> </strong><strong>لم</strong><strong> </strong><strong>تشعر</strong><strong> </strong><strong>بتحسن</strong></p><p dir="RTL"><strong>لا</strong><strong> </strong><strong>يخفي</strong><strong> </strong><strong>بادو</strong><strong>&nbsp; </strong><strong>الأعراض</strong><strong> </strong><strong>الخاصة</strong><strong> </strong><strong>بك</strong><strong> </strong><strong>على</strong><strong> </strong><strong>الفور</strong> - جميع مضادات الاكتئاب تستغرق وقتا طويلا للعمل. سوف يبدأ بعض الناس يشعرون على نحو أفضل في غضون بضعة أسابيع، ولكن بالنسبة لآخرين فإنه قد يستغرق وقتا أطول قليلا. بعض الأشخاص الذين يتناولون مضادات الاكتئاب يشعرون بالسوء قبل الشعور بشكل أفضل. إذا لم تبدأ في الشعور بتحسن بعد بضعة أسابيع، يجب العودة إلى طبيبك الذي سوف يقدم النصح لك. يجب على طبيبك أن يطلب أن أراك مرة أخرى بعد بضعة أسابيع من بدء تناول أول جرعة. أخبر طبيبك إذا لم تبدأ تشعر بتحسن.</p><p dir="RTL"><strong>ج</strong><strong>. </strong><strong>إذا</strong><strong> </strong><strong>توقفت</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>بادو</strong><strong>&nbsp; </strong></p><p dir="RTL"><strong>لا</strong><strong> </strong><strong>تتوقف</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>تناول</strong> <strong>بادو</strong>&nbsp; <strong>حتى</strong><strong> </strong><strong>يقول</strong><strong> </strong><strong>لك</strong><strong> </strong><strong>الطبيب</strong><strong> </strong><strong>ذلك</strong></p><p dir="RTL"><strong>عند</strong><strong> </strong><strong>وقف</strong><strong> </strong><strong>بادو</strong> ، سوف يساعدك طبيبك على خفض الجرعة ببطء على مدى عدة أسابيع أو أشهر - وهذا من شأنه أن يساعد في تقليل فرصة حدوث آثار الانسحاب. طريقة واحدة للقيام بذلك هي بتقليل جرعة <strong>بادو</strong> تدريجيا كنت تتناول جرعة 10 ملغم في الأسبوع. معظم الناس يجدون بأن أعراض انسحاب <strong>بادو</strong>&nbsp; تكون خفيفة وتزول من تلقاء نفسها في غضون أسبوعين. وبالنسبة لبعض الناس، قد تكون هذه الأعراض أكثر شدة، أو تستمر لفترة أطول.</p><p dir="RTL"><strong>إذا</strong><strong> </strong><strong>تعرضت</strong><strong> </strong><strong>لحدوث</strong><strong> </strong><strong>آثار</strong><strong> </strong><strong>الانسحاب</strong> عند تخفيض الأقراص، قد يقرر طبيبك بأنه يجب تخفيض الجرعة لديهم بصورة أكثر بطء. إذا حدثت آثار الانسحاب الحادة عند التوقف عن تناول <strong>بادو</strong> ، يرجى مراجعة الطبيب. ويجوز له أن يطلب منك للبدء في تناول الأقراص مرة أخرى، ويمكن تخفيض الجرعة لديهم بصورة أكثر بطء.</p><p dir="RTL">إذا تعرضت لحدوث آثار الانسحاب، سوف تكون قادرا على وقف <strong>بادو</strong> .</p><p dir="RTL">آثار الانسحاب المحتملة عند إيقاف العلاج</p><p dir="RTL">تحدث بعض آثار الانسحاب عند وقفه بشكل متكرر أكثر من غيره.</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>شائعة،</strong><strong> </strong><strong>من</strong><strong> </strong><strong>المحتمل</strong><strong> </strong><strong>أن</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>على</strong><strong> </strong><strong>ما</strong><strong> </strong><strong>يصل</strong><strong> </strong><strong>إلى</strong><strong> </strong><strong>شخص</strong><strong> </strong><strong>في</strong><strong>&nbsp; </strong><strong>كل</strong><strong> 10 </strong><strong>اشخاص</strong><strong>:</strong></p><p dir="RTL">- الشعور بالدوار، عدم الثبات تقلب أو فقدان التوازن</p><p dir="RTL">- الشعور مثل الدبابيس والإبر، الاحساس بالحرقة و(أقل شيوعا) الاحساس بمثل الصدمة الكهربائية، بما في ذلك الرأس</p><p dir="RTL">- قد تطور عند بعض المرضى حدوث أزيز، الهسهسة، صفير، رنين أو أصوات ثابتة أخرى في الأذنين (الطنين) عند تناول <strong>بادو</strong></p><p dir="RTL">- اضطرابات في النوم (أحلام اليقظة والكوابيس، عدم القدرة على النوم)</p><p dir="RTL">- الشعور بالقلق</p><p dir="RTL">- الصداع.</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>غير</strong><strong> </strong><strong>شائعة،</strong><strong> </strong><strong>من</strong><strong> </strong><strong>المحتمل</strong><strong> </strong><strong>أن</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>على</strong><strong> </strong><strong>ما</strong><strong> </strong><strong>يصل</strong><strong> </strong><strong>إلى</strong><strong> </strong><strong>شخص</strong><strong> </strong><strong>في</strong><strong> </strong><strong>كل</strong><strong> 100 </strong><strong>شخص</strong><strong>:</strong></p><p dir="RTL">- الشعور بالغثيان</p><p dir="RTL">- التعرق (بما في ذلك تعرق ليلي)</p><p dir="RTL">- شعور بعدم الراحة أو الهياج</p><p dir="RTL">- رجفة (الاهتزاز)</p><p dir="RTL">- الشعور بالخلط بين أو التيهان</p><p dir="RTL">- الإسهال (براز رخو)</p><p dir="RTL">- الشعور العاطفي أو تعكر المزاج</p><p dir="RTL">- اضطرابات بصرية</p><p dir="RTL">- التصفيق أو ضربات القلب سريعة (خفقان).</p><p dir="RTL"><strong>يرجى</strong><strong> </strong><strong>مراجعة</strong><strong> </strong><strong>طبيبك</strong><strong> </strong><strong>إذا</strong><strong> </strong><strong>كنت</strong><strong> </strong><strong>قلقا</strong><strong> </strong><strong>حول</strong><strong> </strong><strong>آثار</strong><strong> </strong><strong>وقف</strong><strong> </strong><strong>الانسحاب</strong><strong> </strong><strong>عند</strong><strong> </strong><strong>ايقاف</strong> <strong>بادو</strong> .</p><p dir="RTL">إذا كان لديك أي أسئلة أخرى عن استعمال هذا المستحضر، أسأل طبيبك أو الصيدلاني.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، فإن هذا الدواء يمكن أن يتسبب في إحداث آثار جانبية، على الرغم من أن الجميع لا يصاب بها. من المرجح أن تحدث الآثار الجانبية في الأسابيع القليلة الأولى من تناول <strong>بادو</strong> .</p><p dir="RTL"><strong>يجب</strong><strong> </strong><strong>مراجعة</strong><strong> </strong><strong>الطبيب</strong><strong> </strong><strong>اذا</strong><strong> </strong><strong>ظهرت</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>من</strong><strong> </strong><strong>الآثار</strong><strong> </strong><strong>الجانبية</strong><strong> </strong><strong>التالية</strong><strong> </strong><strong>أثناء</strong><strong> </strong><strong>العلاج</strong></p><p dir="RTL">قد تحتاج إلى الاتصال بطبيبك أو الذهاب إلى المستشفى على الفور.</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>غير</strong><strong> </strong><strong>شائعة،</strong><strong> </strong><strong>من</strong><strong> </strong><strong>المحتمل</strong><strong> </strong><strong>أن</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>على</strong><strong> </strong><strong>ما</strong><strong> </strong><strong>يصل</strong><strong> </strong><strong>إلى</strong><strong> </strong><strong>شخص</strong><strong> </strong><strong>في</strong><strong> </strong><strong>كل</strong><strong> 100 </strong><strong>شخص</strong><strong>:</strong></p><p dir="RTL">- إذا كان لديك كدمات أو نزيف غير عادي، بما في ذلك قيء دموي أو تمرير الدم في البراز، اتصل بطبيبك أو اذهب إلى المستشفى على الفور.</p><p dir="RTL">- إذا وجدت أنك لست قادرا على التبول، اتصل بطبيبك أو اذهب إلى المستشفى على الفور.</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>نادرة،</strong><strong> </strong><strong>من</strong><strong> </strong><strong>المحتمل</strong><strong> </strong><strong>أن</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>على</strong><strong> </strong><strong>ما</strong><strong> </strong><strong>يصل</strong><strong> </strong><strong>إلى</strong><strong> </strong><strong>شخص</strong><strong> </strong><strong>في</strong><strong> </strong><strong>كل</strong><strong> 1000 </strong><strong>شخص</strong><strong>:</strong></p><p dir="RTL">- إذا واجهت تشنجات (نوبات)، اتصل بطبيبك أو اذهب إلى المستشفى على الفور.</p><p dir="RTL">- إذا كنت تشعر بعدم الراحة وتشعر وكأنه لا يمكنك الجلوس أو الوقوف دون حراك، قد يكون لديك ما يسمى بالململة. زيادة الجرعة من <strong>بادو</strong>&nbsp; قد تجعل هذه المشاعر تسوء. إذا كنت تشعر بذلك، اتصل بطبيبك.</p><p dir="RTL">- إذا كنت تشعر بالتعب، الضعف أو الخلط وتعاني من الم العضلات، تشنج أو عضلات غير منسقة وهذا قد يكون بسبب انخفاض مستوى الصوديوم في دمك. إذا حدثت هذه الأعراض، اتصل بطبيبك.</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>نادرة</strong><strong> </strong><strong>جدا،</strong><strong> </strong><strong>من</strong><strong> </strong><strong>المحتمل</strong><strong> </strong><strong>أن</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>على</strong><strong> </strong><strong>ما</strong><strong> </strong><strong>يصل</strong><strong> </strong><strong>إلى</strong><strong> </strong><strong>شخص</strong><strong> </strong><strong>في</strong><strong> </strong><strong>كل</strong><strong> 10000 </strong><strong>شخص</strong><strong>:</strong></p><p dir="RTL">- الحساسية، والتي قد تكون شديدة بسبب <strong>بادو</strong> .</p><p dir="RTL">- إذا حدث احمرار وطفح جلدي عقدي، تورم في الجفون والوجه والشفاه أو الفم أو اللسان، بدء الحكة أو صعوبة في التنفس (ضيق التنفس) أو البلع والشعور بالضعف أو بدوار مما أدى إلى انهيار أو فقدان الوعي اتصل بطبيبك أو اذهب إلى المستشفى على الفور.</p><p dir="RTL">- إذا كان لديك بعض أو كل الأعراض التالية قد يكون لديك ما يسمى متلازمة السيروتونين. وتشمل الأعراض: الشعور بالخلط، والشعور بعدم الراحة، التعرق، الهز، والارتعاش، والهلوسة (رؤى أو أصوات غريبة)، الهزات المفاجئة للعضلات أو سرعة ضربات القلب. إذا شعرت بهذا يجب عليك الاتصال بالطبيب.</p><p dir="RTL">- الزرق الحاد.</p><p dir="RTL">إذا أصبحت عينيك مؤلمة وتطور لديك عدم وضوح الرؤية، اتصل بطبيبك.</p><p dir="RTL"><strong>تردد</strong><strong> </strong><strong>غير</strong><strong> </strong><strong>معروف</strong></p><p dir="RTL">كان لبعض الناس أفكار إيذاء أو قتل أنفسهم عند تناول <strong>بادو</strong>&nbsp; أو بعد التوقف عن العلاج.</p><p dir="RTL"><strong>الآثار</strong><strong> </strong><strong>الجانبية</strong><strong> </strong><strong>المحتملة</strong><strong> </strong><strong>الأخرى</strong><strong> </strong><strong>خلال</strong><strong> </strong><strong>فترة</strong><strong> </strong><strong>العلاج</strong></p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>شائعة</strong><strong> </strong><strong>جدا</strong><strong> </strong><strong>،</strong><strong> </strong><strong>من</strong><strong> </strong><strong>المحتمل</strong><strong> </strong><strong>أن</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>على</strong><strong> </strong><strong>أكثر</strong><strong> </strong><strong>من</strong><strong> </strong><strong>شخص</strong><strong> </strong><strong>في</strong><strong> </strong><strong>كل</strong><strong> 10 </strong><strong>أشخاص</strong><strong>:</strong></p><p dir="RTL">- الشعور بالمرض (الغثيان). ان تناول الدواء في الصباح مع الطعام يقلل من فرصة حدوث ذلك.</p><p dir="RTL">- تغيير في الدافع الجنسي أو الاداء الجنسي. على سبيل المثال، عدم وجود نشوة جنسية، وعند الرجال، انتصاب والقذف غير طبيعي.</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>شائعة،</strong><strong> </strong><strong>من</strong><strong> </strong><strong>المحتمل</strong><strong> </strong><strong>أن</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>على</strong><strong> </strong><strong>ما</strong><strong> </strong><strong>يصل</strong><strong> </strong><strong>إلى</strong><strong> </strong><strong>شخص</strong><strong> </strong><strong>في</strong><strong> </strong><strong>كل</strong><strong> 10 </strong><strong>أشخاص</strong><strong>:</strong></p><p dir="RTL">- زيادة في مستوى الكوليسترول في الدم</p><p dir="RTL">- قلة الشهية</p><p dir="RTL">- عدم النوم جيدا (الأرق) أو الشعور بالنعاس</p><p dir="RTL">- أحلام غير طبيعية (بما في ذلك الكوابيس)</p><p dir="RTL">- الشعور بالدوار أو الرجفان (الهزات)</p><p dir="RTL">- الصداع</p><p dir="RTL">- صعوبة في التركيز</p><p dir="RTL">- الشعور بالهياج</p><p dir="RTL">- الشعور بالضعف على نحو غير عادي</p><p dir="RTL">- عدم وضوح الرؤية</p><p dir="RTL">- التثاؤب، جفاف الفم</p><p dir="RTL">- الإسهال أو الإمساك</p><p dir="RTL">- القيء</p><p dir="RTL">- زيادة الوزن</p><p dir="RTL">- التعرق.</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>غير</strong><strong> </strong><strong>شائعة،</strong><strong> </strong><strong>من</strong><strong> </strong><strong>المحتمل</strong><strong> </strong><strong>أن</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>على</strong><strong> </strong><strong>ما</strong><strong> </strong><strong>يصل</strong><strong> </strong><strong>إلى</strong><strong> </strong><strong>شخص</strong><strong> </strong><strong>في</strong><strong> </strong><strong>كل</strong><strong> 100 </strong><strong>شخص</strong><strong>:</strong></p><p dir="RTL">- زيادة وجيزة في ضغط الدم، أو انخفاض موجز الذي قد يجعلك تشعر بالدوار أو الإغماء عند الوقوف فجأة</p><p dir="RTL">- ضربات القلب أسرع من الطبيعي</p><p dir="RTL">- عدم وجود حركة، صلابة، والهز أو تحركات غير طبيعية في الفم واللسان</p><p dir="RTL">- اتساع حدقة العين</p><p dir="RTL">- طفح جلدي</p><p dir="RTL">- حكة</p><p dir="RTL">- الشعور بالخلط</p><p dir="RTL">- وجود هلوسة (رؤى أو أصوات غريبة)</p><p dir="RTL">- عدم القدرة على التبول (احتباس البول) أو، تبول غير طوعي لا يمكن السيطرة عليه عابرة (سلس البول)</p><p dir="RTL">- إذا كنت مريض سكري قد تلاحظ فقدان السيطرة على مستويات السكر في الدم عند تناول <strong>بادو</strong> . يرجى التحدث مع طبيبك حول ضبط جرعة الأنسولين الخاصة بك أو مرض السكري الأدوية.</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>نادرة،</strong><strong> </strong><strong>من</strong><strong> </strong><strong>المحتمل</strong><strong> </strong><strong>أن</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>على</strong><strong> </strong><strong>ما</strong><strong> </strong><strong>يصل</strong><strong> </strong><strong>إلى</strong><strong> </strong><strong>شخص</strong><strong> </strong><strong>في</strong><strong> </strong><strong>كل</strong><strong> 1000 </strong><strong>شخص</strong><strong>:</strong></p><p dir="RTL">- إنتاج غير طبيعي من حليب الثدي لدى الرجال والنساء</p><p dir="RTL">- بطء ضربات القلب</p><p dir="RTL">- التأثيرات على الكبد تظهر في اختبارات وظائف الكبد الخاصة بك</p><p dir="RTL">- نوبات الذعر</p><p dir="RTL">- السلوك مفرط أو أفكار (الهوس)</p><p dir="RTL">- الشعور بالبعد عن النفس (تبدد الشخصية)</p><p dir="RTL">- الشعور بالقلق</p><p dir="RTL">- رغبة لا تقاوم بتحريك الساقين (متلازمة تململ الساقين)</p><p dir="RTL">- ألم في المفاصل أو العضلات</p><p dir="RTL">- زيادة في هرمون البرولاكتين في الدم</p><p dir="RTL">- اضطرابات الدورة الشهرية (بما في ذلك دورات ثقيلة أو غير منتظمة، ونزيف بين الدورات وغياب أو تأخير الدورة)</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>نادرة</strong><strong> </strong><strong>جدا،</strong><strong> </strong><strong>من</strong><strong> </strong><strong>المحتمل</strong><strong> </strong><strong>أن</strong><strong> </strong><strong>تؤثر</strong><strong> </strong><strong>على</strong><strong> </strong><strong>ما</strong><strong> </strong><strong>يصل</strong><strong> </strong><strong>إلى</strong><strong> </strong><strong>شخص</strong><strong> </strong><strong>في</strong><strong> </strong><strong>كل</strong><strong> 10000 </strong><strong>شخص</strong><strong>:</strong></p><p dir="RTL">- طفح جلدي، والذي قد يكون على شكل نفطة، ويبدو وكأنه أهداف صغيرة (بقع قاتمة مركزية تحيط بها منطقة فاتحة، مع حلقة قاتمة حول الحافة) تسمى حمامي متعددة الأشكال</p><p dir="RTL">- طفح جلدي على نطاق واسع مع ظهور بثور وتقشير في الجلد، وخاصة حول الفم والأنف والعينين والأعضاء التناسلية (متلازمة ستيفنز جونسون)</p><p dir="RTL">- طفح جلدي على نطاق واسع مع ظهور بثور وتقشير البشرة على جزء كبير من سطح الجسم (انحلال البشرة السمي)</p><p dir="RTL">- مشاكل في الكبد التي تعمل على اصفرار لون الجلد أو بياض العينين</p><p dir="RTL">- متلازمة إنتاج غير مناسب للهرمون المضاد لإدرار البول (SIADH) الذي هو حالة في الجسم ينتج عنه وجود فائض من المياه وانخفاض في تركيز الصوديوم (الملح)، نتيجة لإشارات كيميائية غير صحيحة. المرضى الذين يعانون من SIADH قد يمرضون بشدة أو قد لا يعانون من أيه أعراض على الإطلاق</p><p dir="RTL">- احتباس السائل أو الماء (والذي قد يسبب تورم في الذراعين أو الساقين)</p><p dir="RTL">- حساسية لأشعة الشمس</p><p dir="RTL">- انتصاب مؤلم للقضيب</p><p dir="RTL">- انخفاض عدد الصفائح الدموية في الدم.</p><p dir="RTL">- قد عانى بعض المرضى من الأزيز، الهسهسة، صفير، رنين أو ضوضاء آخرى مستمرة في الأذنين (طنين) عند تناول <strong>بادو</strong> .</p><p dir="RTL">- قد لوحظ زيادة خطر حدوث كسور العظام في المرضى الذين يتناولون هذا النوع من الدواء.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">- يحفظ بعيدا عن متناول وبصر الأطفال.</p><p dir="RTL">- يحفظ دون 30&deg; م، في مكان جاف</p><p dir="RTL">- لا تستعمل <strong>بادو</strong> بعد تاريخ انتهاء الصلاحية التي توضع على العلبة الخارجية. يشير تاريخ الانتهاء إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">- يجب عدم التخلص من الأدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلاني عن كيفية التخلص من الأدوية التي لم تعد مطلوبة. وسوف تساعد هذه التدابير في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">- المادة الفعالة هي: باروكسيتين.</p><p dir="RTL"><strong>بادو</strong>&nbsp;<strong>20:</strong> كل قرص مغلف يحتوي على باروكسيتين هايدروكلورايد ما يعادل 20 ملغم باروكسيتين.</p><p dir="RTL">- المكونات الأخرى هي: كالسيوم فوسفات الهيدروجين، نشا غليكولات الصوديوم، ماغنيسيوم ستيرات وأوبادراي أبيض.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">- أقراص مغلفة .</p><p dir="RTL">- الوصف الخارجي: أقراص بيضاء مغلفة بيضاوية الشكل محدبة الوجهين، قابلة للانقسام في جانب واحد ومنقوش عليها رمز &ldquo;I 77&rdquo; على الجانب الآخر.</p><p dir="RTL">- <strong>بادو</strong>&nbsp; 20 معبأ في أشرطة المونيوم بيضاء اللون من مادتي PVC/PVCD، موضوعة في عبوات كرتونية مع نشرات طبية متعددة الطي.</p><p dir="RTL">- حجم العبوة: يتوفر <strong>بادو</strong> <strong>20</strong> في عبوات سعة 30 قرص مغلف (10 أقراص/شريط، 3 أشرطة/ العبوة).</p><p dir="RTL">عبوات المستشفيات متوفرة أيضاً.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">الشركة المتحدة لصناعة الأدوية ذ.م.م</p><p dir="RTL">هاتف: 4162901 (6) 962+</p><p dir="RTL">فاكس: 4162905 (6) 962+</p><p dir="RTL">البريد الإلكتروني: info@upm.com.jo</p><p dir="RTL">&nbsp;</p><p dir="RTL">لأي معلومات عن هذا الدواء، يرجى الاتصال بالممثل المحلي للشركة مالكة رخصة التسويق:</p><p dir="RTL">مؤسسات سقالة</p><p dir="RTL">ص.ب. 19435، جدة 21435-السعودية</p><p dir="RTL">الهاتف: 966126136740+</p><p dir="RTL">فاكس:&nbsp; 96626148458 +</p><p dir="RTL">البريد الإلكتروني: info.reg@cigalah.com.sa&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            . تمت املوافقة على هذه النشرة بتاريخ2020 / 4 ؛ رقم النسخة :
M3-14-1304
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                PADO® 20mg Film Coated Tablet
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Paroxitine HCL 23.3MG/TABLET
For a full list of excipients, see section 6.1 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film Coated Tablets
− PADO® 20mg F/C Tablets: Oval-shaped white biconvex film coated tablet, scored at one
side and embossed with “I 77” on other side.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment of<br />- Major Depressive Episode<br />- Obsessive Compulsive Disorder<br />- Panic Disorder with and without agoraphobia<br />- Social Anxiety Disorders/Social phobia<br />- Generalised Anxiety Disorder<br />- Post-Traumatic Stress Disorder</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Route of administration: Oral.<br />Posology<br />- MAJOR DEPRESSIVE EPISODE</p><p>- The recommended dose is 20 mg daily. In general, improvement in patients starts after one<br />week but may only become evident from the second week of therapy.<br />- As with all antidepressant medicinal products, dosage should be reviewed and adjusted if<br />necessary within 3 to 4 weeks of initiation of therapy and thereafter as judged clinically<br />appropriate. In some patients, with insufficient response to 20 mg, the dose may be<br />increased gradually up to a maximum of 50 mg a day in 10 mg steps according to the<br />patient&#39;s response.<br />- Patients with depression should be treated for a sufficient period of at least 6 months to<br />ensure that they are free from symptoms.<br />- OBSESSIVE COMPULSIVE DISORDER<br />- The recommended dose is 40 mg daily. Patients should start on 20 mg/day and the dose<br />may be increased gradually in 10 mg increments to the recommended dose. If after some<br />weeks on the recommended dose insufficient response is seen some patients may benefit<br />from having their dose increased gradually up to a maximum of 60 mg/day.<br />- Patients with OCD should be treated for a sufficient period to ensure that they are free from<br />symptoms. This period may be several months or even longer .<br />- PANIC DISORDER<br />- The recommended dose is 40 mg daily. Patients should be started on 10 mg/day and the<br />dose gradually increased in 10 mg steps according to the patient&#39;s response up to the<br />recommended dose. A low initial starting dose is recommended to minimise the potential<br />worsening of panic symptomatology, which is generally recognised to occur early in the<br />treatment of this disorder. If after some weeks on the recommended dose insufficient<br />response is seen some patients may benefit from having their dose increased gradually up<br />to a maximum of 60 mg/day.<br />- Patients with panic disorder should be treated for a sufficient period to ensure that they are<br />free from symptoms. This period may be several months or even longer .<br />- SOCIAL ANXIETY DISORDER/SOCIAL PHOBIA<br />- The recommended dose is 20 mg daily. If after some weeks on the recommended dose<br />insufficient response is seen some patients may benefit from having their dose increased<br />gradually in 10 mg steps up to a maximum of 50 mg/day. Long-term use should be<br />regularly evaluated<br />- GENERALISED ANXIETY DISORDER<br />- The recommended dose is 20 mg daily. If after some weeks on the recommended dose<br />insufficient response is seen some patients may benefit from having their dose increased<br />gradually in 10 mg steps up to a maximum of 50 mg/day. Long-term use should be<br />regularly evaluated.<br />- POST-TRAUMATIC STRESS DISORDER<br />- The recommended dose is 20 mg daily. If after some weeks on the recommended dose<br />insufficient response is seen some patients may benefit from having their dose increased<br />gradually in 10 mg steps up to a maximum of 50 mg/day. Long-term use should be<br />regularly evaluated.<br />- GENERAL INFORMATION<br />- WITHDRAWAL SYMPTOMS SEEN ON DISCONTINUATION OF PAROXETINE<br />- Abrupt discontinuation should be avoided. The taper phase regimen used involved<br />decreasing the daily dose by 10 mg at weekly intervals. If intolerable symptoms occur<br />following a decrease in the dose or upon discontinuation of treatment, then resuming the&nbsp;previously prescribed dose may be considered. Subsequently, the physician may continue<br />decreasing the dose, but at a more gradual rate.<br />- Special Populations:<br />- Older people<br />- Increased plasma concentrations of paroxetine occur in elderly subjects, but the range of<br />concentrations overlaps with that observed in younger subjects. Dosing should commence<br />at the adult starting dose. Increasing the dose might be useful in some patients, but the<br />maximum dose should not exceed 40 mg daily.<br />- Children and adolescents (7-17 years)<br />- Paroxetine should not be used for the treatment of children and adolescents, paroxetine to<br />be associated with increased risk for suicidal behaviour and hostility. In addition, efficacy<br />has not been adequately demonstrated.<br />- Children aged below 7 years<br />- Paroxetine should not be used, as long as safety and efficacy in this age group have not<br />been established.<br />- Renal/hepatic impairment<br />- Increased plasma concentrations of paroxetine occur in patients with severe renal<br />impairment (creatinine clearance less than 30 ml/min) or in those with hepatic impairment.<br />Therefore, dosage should be restricted to the lower end of the dosage range.<br />Method of administration<br />- It is recommended that paroxetine is administered once daily in the morning with food.<br />- The tablet should be swallowed rather than chewed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance(s) or to any of the excipients
Paroxetine is contraindicated in combination with monoamine oxidase inhibitors (MAOIs). In
exceptional circumstances, linezolid (an antibiotic which is a reversible non-selective MAOI) can
be given in combination with paroxetine provided that there are facilities for close observation of
symptoms of serotonin syndrome and monitoring of blood pressure.
Treatment with paroxetine can be initiated:
- two weeks after discontinuation of an irreversible MAOI, or
- at least 24hrs after discontinuation of a reversible MAOI (e.g. moclobemide, linezolid,
methylthioninium chloride (methylene blue); a preoperative visualising agent which is a reversible
non-selective MAOI)).
At least one week should elapse between discontinuation of paroxetine and initiation of therapy
with any MAOI.
Paroxetine should not be used in combination with thioridazine, because, as with other drugs
which inhibit the hepatic enzyme CYP450 2D6, paroxetine can elevate plasma levels of
thioridazine. Administration of thioridazine alone can lead to QTc interval prolongation with
associated serious ventricular arrhythmia such as torsades de pointes, and sudden death.
Paroxetine should not be used in combination with pimozide.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment with paroxetine should be initiated cautiously two weeks after terminating<br />treatment with an irreversible MAOI or 24 hours after terminating treatment with a&nbsp;reversible MAO inhibitor. Dosage of paroxetine should be increased gradually until an<br />optimal response is reached.<br />- Paediatric population<br />- Paroxetine should not be used in the treatment of children and adolescents under the age of<br />18 years. Suicide-related behaviours (suicide attempt and suicidal thoughts), and hostility<br />(predominantly aggression, oppositional behaviour and anger) were more frequently<br />observed among children and adolescents treated with antidepressants. If, based on clinical<br />need, a decision to treat is nevertheless taken, the patient should be carefully monitored for<br />the appearance of suicidal symptoms. In addition, long-term safety data in children and<br />adolescents concerning growth, maturation and cognitive and behavioural development are<br />lacking.<br />- Suicide/suicidal thoughts or clinical worsening<br />- Depression is associated with an increased risk of suicidal thoughts, self harm and suicide<br />(suicide-related events). This risk persists until significant remission occurs. As<br />improvement may not occur during the first few weeks or more of treatment, patients<br />should be closely monitored until such improvement occurs. It is general clinical<br />experience that the risk of suicide may increase in the early stages of recovery.<br />- Other psychiatric conditions for which paroxetine are prescribed can also be associated<br />with an increased risk of suicide-related events. In addition, these conditions may be comorbid<br />with major depressive disorder. The same precautions observed when treating<br />patients with major depressive disorder should therefore be observed when treating patients<br />with other psychiatric disorders.<br />- Patients with a history of suicide-related events, or those exhibiting a significant degree of<br />suicidal ideation prior to commencement of treatment are known to be at greater risk of<br />suicidal thoughts or suicide attempts, and should receive careful monitoring during<br />treatment.<br />- Close supervision of patients and in particular those at high risk should accompany drug<br />therapy especially in early treatment and following dose changes. Patients (and caregivers<br />of patients) should be alerted about the need to monitor for any clinical worsening, suicidal<br />behaviour or thoughts and unusual changes in behaviour and to seek medical advice<br />immediately if these symptoms present.<br />- Akathisia/psychomotor restlessness<br />- The use of paroxetine has been associated with the development of akathisia, which is<br />characterized by an inner sense of restlessness and psychomotor agitation such as an<br />inability to sit or stand still usually associated with subjective distress. This is most likely<br />to occur within the first few weeks of treatment. In patients who develop these symptoms,<br />increasing the dose may be detrimental.<br />- Serotonin Syndrome/Neuroleptic Malignant Syndrome<br />- On rare occasions development of a serotonin syndrome or neuroleptic malignant<br />syndrome-like events may occur in association with treatment of paroxetine, particularly<br />when given in combination with other serotonergic and/or neuroleptic drugs. As these<br />syndromes may result in potentially life-threatening conditions, treatment with paroxetine<br />should be discontinued if such events (characterised by clusters of symptoms such as<br />hyperthermia, rigidity, myoclonus, autonomic instability with possible rapid fluctuations of<br />vital signs, mental status changes including confusion, irritability, extreme agitation<br />progressing to delirium and coma) occur and supportive symptomatic treatment should be&nbsp;initiated. Paroxetine should not be used in combination with serotonin-precursors (such as<br />L-tryptophan, oxitriptan) due to the risk of serotonergic syndrome.<br />- Mania<br />- As with all antidepressants, paroxetine should be used with caution in patients with a<br />history of mania. Paroxetine should be discontinued in any patient entering a manic phase.<br />- Renal/hepatic impairment<br />- Caution is recommended in patients with severe renal impairment or in those with hepatic<br />impairment.<br />- Diabetes<br />- In patients with diabetes, treatment with an SSRI may alter glycaemic control. Insulin<br />and/or oral hypoglycaemic dosage may need to be adjusted. Additionally, an increase in<br />blood glucose levels may occur when paroxetine and pravastatin are co-administered.<br />- Epilepsy<br />- As with other antidepressants, paroxetine should be used with caution in patients with<br />epilepsy.<br />- Seizures<br />- Overall the incidence of seizures is less than 0.1% in patients treated with paroxetine. The<br />drug should be discontinued in any patient who develops seizures.<br />- Electroconvulsive therapy (ECT)<br />- There is little clinical experience of the concurrent administration of paroxetine with ECT.<br />- Glaucoma<br />- As with other SSRIs, paroxetine can cause mydriasis and should be used with caution in<br />patients with narrow angle glaucoma or history of glaucoma.<br />- Cardiac Conditions<br />- The usual precautions should be observed in patients with cardiac conditions.<br />- Hyponatraemia<br />- Hyponatraemia has been reported rarely, predominantly in the elderly. Caution should also<br />be exercised in those patients at risk of hyponatraemia e.g. from concomitant medications<br />and cirrhosis. The hyponatraemia generally reverses on discontinuation of paroxetine.<br />- Haemorrhage<br />- SSRIs/SNRIs may increase the risk of postpartum hemorrhage.<br />- There have been reports of cutaneous bleeding abnormalities such as ecchymoses and<br />purpura with SSRIs. Other haemorrhagic manifestations e.g. gastrointestinal and<br />gynaecological haemorrhage have been reported. Elderly patients may be at an increased<br />risk for non-menses related events of bleeding.<br />- Caution is advised in patients taking SSRIs concomitantly with oral anticoagulants, drugs<br />known to affect platelet function or other drugs that may increase risk of bleeding (e.g.<br />atypical antipsychotics such as clozapine, phenothiazines, most TCAs, acetylsalicylic acid,<br />NSAIDs, COX-2 inhibitors) as well as in patients with a history of bleeding disorders or<br />conditions which may predispose to bleeding.<br />- Interaction with tamoxifen<br />- Paroxetine, a potent inhibitor of CYP2D6, may lead to reduced concentrations of<br />endoxifen, one of the most important active metabolites of tamoxifen. Therefore,<br />paroxetine should whenever possible be avoided during tamoxifen treatment.</p><p>Drugs affecting gastric pH<br />- In patients receiving oral suspension, the paroxetine plasma concentration may be<br />influenced by gastric pH. In vitro data have shown that an acidic environment is required<br />for release of the active drug from the suspension, hence absorption may be reduced in<br />patients with a high gastric pH or achlorhydria, such as after the use of certain drugs<br />(antacid drugs, histamine H2-receptor antagonists, proton pump inhibitors), in certain<br />disease states (e.g. atrophic gastritis, pernicious anemia, chronic Helicobacter<br />pylori infection), and after surgery (vagotomy, gastrectomy). The pH dependency should<br />be taken into account when changing paroxetine formulation (e.g. the plasma paroxetine<br />concentration may decrease after changing from tablet to oral suspension in patients with a<br />high gastric pH). Caution is therefore recommended in patients when initiating or ending<br />treatment with drugs increasing gastric pH. Dose adjustments may be necessary in such<br />situations.<br />- Withdrawal symptoms seen on discontinuation of paroxetine treatment<br />- Withdrawal symptoms when treatment is discontinued are common, particularly if<br />discontinuation is abrupt. adverse events seen on treatment discontinuation occurred in<br />30% of patients treated with paroxetine. The occurrence of withdrawal symptoms is not the<br />same as the drug being addictive or dependence producing.<br />- The risk of withdrawal symptoms may be dependent on several factors including the<br />duration and dose of therapy and the rate of dose reduction.<br />- Dizziness, sensory disturbances (including paraesthesia, electric shock sensations and<br />tinnitus), sleep disturbances (including intense dreams), agitation or anxiety, nausea,<br />tremor, confusion, sweating, headache, diarrhoea, palpitations, emotional instability,<br />irritability, and visual disturbances have been reported. Generally these symptoms are mild<br />to moderate; however, in some patients they may be severe in intensity. They usually occur<br />within the first few days of discontinuing treatment, but there have been very rare reports<br />of such symptoms in patients who have inadvertently missed a dose. Generally these<br />symptoms are self-limiting and usually resolve within two weeks, though in some<br />individuals they may be prolonged (two-three months or more). It is therefore advised that<br />paroxetine should be gradually tapered when discontinuing treatment over a period of<br />several weeks or months, according to the patient&#39;s needs</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Serotonergic drugs<br />As with other SSRIs, co-administration with serotonergic drugs may lead to an incidence of 5-HT<br />associated effects. Caution should be advised and a closer clinical monitoring is required when<br />serotonergic drugs (such as L-tryptophan, triptans, tramadol, linezolid, methylthioninium chloride<br />(methylene blue)), SSRIs, lithium, pethidine and St. John&#39;s Wort &ndash; Hypericum perforatum &ndash;<br />preparations) are combined with paroxetine. Caution is also advised with fentanyl used in general<br />anaesthesia or in the treatment of chronic pain. Concomitant use of paroxetine and MAOIs is<br />contraindicated because of the risk of serotonin.<br />Pimozide<br />Increased pimozide levels of on average 2.5. This may be explained by the known CYP2D6<br />inhibitory properties of paroxetine. Due to the narrow therapeutic index of pimozide and its known<br />ability to prolong QT interval, concomitant use of pimozide and paroxetine is contraindicated.</p><p>Drug metabolising enzymes<br />The metabolism and pharmacokinetics of paroxetine may be affected by the induction or inhibition<br />of drug metabolising enzymes.<br />When paroxetine is to be co-administered with a known drug metabolising enzyme inhibitor,<br />consideration should be given to using paroxetine doses at the lower end of the range.<br />No initial dosage adjustment is considered necessary when the drug is to be co-administered with<br />known drug metabolising enzyme inducers (e.g. carbamazepine, rifampicin, phenobarbital,<br />phenytoin) or with fosamprenavir/ritonavir. Any paroxetine dosage adjustment (either after<br />initiation or following discontinuation of an enzyme inducer) should be guided by clinical effect<br />(tolerability and efficacy).<br />Neuromuscular Blockers<br />SSRIs may reduce plasma cholinesterase activity resulting in a prolongation of the neuromuscular<br />blocking action of mivacurium and suxamethonium.<br />Fosamprenavir/ritonavir: Co-administration of fosamprenavir/ritonavir 700/100 mg twice daily<br />with paroxetine 20 mg daily in healthy volunteers for 10 days significantly decreased plasma<br />levels of paroxetine by approximately 55%. Paroxetine had no significant effect on metabolism of<br />fosamprenavir/ritonavir. There are no data available about the effects of long-term coadministration<br />of paroxetine and fosamprenavir/ritonavir exceeding 10 days.<br />Procyclidine: Daily administration of paroxetine increases significantly the plasma levels of<br />procyclidine. If anti-cholinergic effects are seen, the dose of procyclidine should be reduced.<br />Anticonvulsants: carbamazepine, phenytoin, sodium valproate. Concomitant administration does<br />not seem to show any effect on pharmacokinetic/dynamic profile in epileptic patients.<br />CYP2D6 inhibitory potency of paroxetine<br />As with other antidepressants, including other SSRIs, paroxetine inhibits the hepatic cytochrome<br />P450 enzyme CYP2D6. Inhibition of CYP2D6 may lead to increased plasma concentrations of coadministered<br />drugs metabolised by this enzyme. These include certain tricyclic antidepressants<br />(e.g. clomipramine, nortriptyline, and desipramine), phenothiazine neuroleptics (e.g. perphenazine<br />and thioridazine, see section 4.3 Contraindications), risperidone, atomoxetine, certain Type 1c<br />antiarrhythmics (e.g. propafenone and flecainide) and metoprolol. It is not recommended to use<br />paroxetine in combination with metoprolol when given in cardiac insufficiency, because of the<br />narrow therapeutic index of metoprolol in this indication.<br />Pharmacokinetic interaction between CYP2D6 inhibitors and tamoxifen, showing a 65-75%<br />reduction in plasma levels of one of the more active forms of tamoxifen, i.e. endoxifen, has been<br />reported in the literature. Reduced efficacy of tamoxifen has been reported with concomitant usage<br />of some SSRI antidepressants. As a reduced effect of tamoxifen cannot be excluded, coadministration<br />with potent CYP2D6 inhibitors (including paroxetine) should whenever possible be avoided.<br />Alcohol<br />As with other psychotropic drugs patients should be advised to avoid alcohol use while taking paroxetine.<br />Oral anticoagulants<br />A pharmacodynamic interaction between paroxetine and oral anticoagulants may occur.<br />Concomitant use of paroxetine and oral anticoagulants can lead to an increased anticoagulant<br />activity and haemorrhagic risk. Therefore, paroxetine should be used with caution in patients who<br />are treated with oral anticoagulants.</p><p>NSAIDs and acetylsalicylic acid, and other antiplatelet agents<br />A pharmacodynamic interaction between paroxetine and NSAIDs/acetylsalicylic acid may occur.<br />Concomitant use of paroxetine and NSAIDs/acetylsalicylic acid can lead to an increased<br />haemorrhagic risk.<br />Caution is advised in patients taking SSRIs, concomitantly with oral anticoagulants, drugs known<br />to affect platelet function or increase risk of bleeding (e.g. atypical antipsychotics such as<br />clozapine, phenothiazines, most TCAs, acetylsalicylic acid, NSAIDs, COX-2 inhibitors) as well as<br />in patients with a history of bleeding disorders or conditions that may predispose to bleeding.<br />Pravastatin<br />An interaction between paroxetine and pravastatin has been observed suggesting that coadministration<br />of paroxetine and pravastatin may lead to an increase in blood glucose levels.<br />Patients with diabetes mellitus receiving both paroxetine and pravastatin may require dosage<br />adjustment of oral hypoglycaemic agents and/or insulin.<br />Drugs affecting gastric pH<br />Drugs that alter gastric pH (such as antacid drugs, proton pump inhibitors or histamine H2-receptor<br />antagonists) may affect plasma paroxetine concentrations in patients taking the oral suspension</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy:<br />Some epidemiological studies suggest an increased risk of congenital malformations, particularly<br />cardiovascular (e.g. ventricular and atrial septum defects), associated with the use of paroxetine<br />during the first trimester. The mechanism is unknown. The data suggest that the risk of having an<br />infant with a cardiovascular defect following maternal paroxetine exposure is less than 2/100<br />compared with an expected rate for such defects of approximately 1/100 in the general population.<br />Paroxetine should only be used during pregnancy when strictly indicated. The prescribing<br />physician will need to weigh the option of alternative treatments in women who are pregnant or are<br />planning to become pregnant. Abrupt discontinuation should be avoided during pregnancy.<br />Neonates should be observed if maternal use of paroxetine continues into the later stages of<br />pregnancy, particularly the third trimester.<br />The following symptoms may occur in the neonate after maternal paroxetine use in later stages of<br />pregnancy: respiratory distress, cyanosis, apnoea, seizures, temperature instability, feeding<br />difficulty, vomiting, hypoglycaemia, hypertonia, hypotonia, hyperreflexia, tremor, jitteriness,<br />irritability, lethargy, constant crying, somnolence and difficulty in sleeping. These symptoms could<br />be due to either serotonergic effects or withdrawal symptoms. In a majority of instances the<br />complications begin immediately or soon (&lt;24 hours) after delivery.<br />Epidemiological data have suggested that the use of SSRIs in pregnancy, particularly in late<br />pregnancy, may have an increased risk of persistent pulmonary hypertension of the newborn<br />(PPHN). The observed risk was approximately five cases per 1000 pregnancies. In the general<br />population one to two cases of PPHN per 1000 pregnancies occur.<br />Observational data indicate an increased risk (less than 2-fold) of postpartum hemorrhage<br />following SSRI/SNRI exposure within the month prior to birth.<br />Breast-feeding<br />Small amounts of paroxetine are excreted into breast milk. Serum concentrations in breast-fed<br />infants were undetectable (&lt;2 nanograms/ml) or very low (&lt;4 nanograms/ml), and no signs of drug<br />effects were observed in these infants. Since no effects are anticipated, breast-feeding can be<br />considered.</p><p>Fertility<br />Human case reports with some SSRIs (including paroxetine) have shown that an effect on sperm<br />quality appears to be reversible.<br />Impact on human fertility has not been observed so far.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Clinical experience has shown that therapy with paroxetine is not associated with impairment of<br />cognitive or psychomotor function. However, as with all psychoactive drugs, patients should be<br />cautioned about their ability to drive a car and operate machinery.<br />Although paroxetine does not increase the mental and motor skill impairments caused by alcohol,<br />the concomitant use of paroxetine and alcohol is not advised</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Some of the adverse drug reactions listed below may decrease in intensity and frequency with<br />continued treatment and do not generally lead to cessation of therapy. Adverse drug reactions are<br />listed below by system organ class and frequency. Frequencies are defined as: very common (&ge;<br />1/10), common (&ge; 1/100, &lt;1/10), uncommon (&ge; 1/1,000, &lt;1/100), rare (&ge; 1/10,000, &lt;1/1,000), very<br />rare (&lt;1/10,000), including isolated reports.<br />Blood and lymphatic system disorders<br />Uncommon: abnormal bleeding, predominantly of the skin and mucous membranes (including<br />ecchymosis and gynaecological bleeding).<br />Very rare: thrombocytopenia.<br />Immune system disorders<br />Very rare: severe and potentially fatal allergic reactions (including anaphylactoid reactions and<br />angioedema).<br />Endocrine disorders<br />Very rare: syndrome of inappropriate anti-diuretic hormone secretion (SIADH).<br />Metabolism and nutrition disorders<br />Common: increases in cholesterol levels, decreased appetite.<br />Uncommon: altered glycaemic control has been reported in diabetic patients.<br />Rare: hyponatraemia.<br />Hyponatraemia has been reported predominantly in elderly patients and is sometimes due to<br />syndrome of inappropriate anti-diuretic hormone secretion (SIADH).<br />Psychiatric disorders<br />Common: somnolence, insomnia, agitation, abnormal dreams (including nightmares).<br />Uncommon: confusion, hallucinations.<br />Rare: manic reactions, anxiety, depersonalisation, panic attacks, akathisia.<br />Frequency not known: suicidal ideation and suicidal behaviour.<br />Cases of suicidal ideation and suicidal behaviour have been reported during paroxetine therapy or<br />early after treatment discontinuation.<br />These symptoms may also be due to the underlying disease<br />Nervous system disorders<br />Common: dizziness, tremor, headache, concentration impaired.<br />Uncommon: extrapyramidal disorders.<br />Rare: convulsions, restless legs syndrome (RLS).</p><p>Very rare: serotonin syndrome (symptoms may include agitation, confusion, diaphoresis,<br />hallucinations, hyperreflexia, myoclonus, shivering, tachycardia and tremor).<br />Reports of extrapyramidal disorder including oro-facial dystonia have been received in patients<br />sometimes with underlying movement disorders or who were using neuroleptic medication.<br />Eye disorders<br />Common: blurred vision.<br />Uncommon: mydriasis.<br />Very rare: acute glaucoma.<br />Ear and labyrinth disorders<br />Frequency not known: tinnitus.<br />Cardiac disorders<br />Uncommon: sinus tachycardia.<br />Rare: bradycardia.<br />Vascular disorders<br />Uncommon: transient increases or decreases in blood pressure, postural hypotension.<br />Transient increases or decreases of blood pressure have been reported following treatment with<br />paroxetine, usually in patients with pre-existing hypertension or anxiety.<br />Respiratory, thoracic and mediastinal disorders<br />Common: yawning.<br />Gastrointestinal disorders<br />Very common: nausea.<br />Common: constipation, diarrhoea, vomiting, dry mouth.<br />Very rare: gastrointestinal bleeding.<br />Unknown : Colitis microscopic<br />Hepato-biliary disorders<br />Rare: elevation of hepatic enzymes.<br />Very rare: hepatic events (such as hepatitis, sometimes associated with jaundice and/or liver failure).<br />Elevation of hepatic enzymes has been reported. Post-marketing reports of hepatic events (such as<br />hepatitis, sometimes associated with jaundice and/or liver failure) have also been received very<br />rarely. Discontinuation of paroxetine should be considered if there is prolonged elevation of liver<br />function test results.<br />Skin and subcutaneous tissue disorders<br />Common: sweating.<br />Uncommon: skin rashes, pruritus<br />Very rare: severe cutaneous adverse reactions (including erythema multiforme, Stevens-Johnson<br />syndrome and toxic epidermal necrolysis), urticaria, and photosensitivity reactions.<br />Renal and urinary disorders<br />Uncommon: urinary retention, urinary incontinence.<br />Reproductive system and breast disorders<br />Very common: sexual dysfunction.<br />Rare: hyperprolactinaemia/galactorrhoea, menstrual disorders (including menorrhagia,<br />metrorrhagia, amenorrhoea, menstruation delayed and menstruation irregular).<br />Very rare: priapism<br />Postpartum haemorrhage*; frequency not known.<br />* This event has been reported for the therapeutic class of SSRIs/SNRIs</p><p>Musculoskeletal and connective tissue disorders<br />Rare: arthralgia, myalgia<br />In patients 50 years of age and older, show an increased risk of bone fractures in patients receiving<br />SSRIs and TCAs. The mechanism leading to this risk is unknown.<br />General disorder and administration site conditions<br />Common: asthenia, body weight gain<br />Very rare: peripheral oedema.<br />WITHDRAWAL SYMPTOMS SEEN ON DISCONTINUATION OF PAROXETINE<br />TREATMENT<br />Common: dizziness, sensory disturbances, sleep disturbances, anxiety, headache.<br />Uncommon: agitation, nausea, tremor, confusion, sweating, emotional instability, visual<br />disturbances, palpitations, diarrhoea, irritability.<br />Discontinuation of paroxetine (particularly when abrupt) commonly leads to withdrawal<br />symptoms. Dizziness, sensory disturbances (including paraesthesia, electric shock sensations and<br />tinnitus), sleep disturbances (including intense dreams), agitation or anxiety, nausea, tremor,<br />confusion, sweating, headache, diarrhoea, palpitations, emotional instability, irritability, and visual<br />disturbances have been reported.<br />Generally these events are mild to moderate and are self-limiting; however, in some patients they<br />may be severe and/or prolonged. It is therefore advised that when paroxetine treatment is no longer<br />required, gradual discontinuation by dose tapering should be carried out<br />ADVERSE EVENTS in PAEDIATRIC<br />The following adverse events were observed:<br />Increased suicidal related behaviours (including suicide attempts and suicidal thoughts), self-harm<br />behaviours and increased hostility. Suicidal thoughts and suicide attempts were mainly observed in<br />adolescents with Major Depressive Disorder. Increased hostility occurred particularly in children<br />with obsessive compulsive disorder and especially in younger children less than 12 years of age.<br />Additional events that were seen are: decreased appetite, tremor, sweating, hyperkinesia, agitation,<br />emotional lability (including crying and mood fluctuations), bleeding related adverse events,<br />predominantly of the skin and mucous membranes.<br />Events seen after discontinuation/tapering of paroxetine are: emotional lability (including crying,<br />mood fluctuations, self-harm, suicidal thoughts and attempted suicide), nervousness, dizziness,<br />nausea and abdominal pain.<br />To report any side effect(s):<br />&bull; Saudi Arabia:<br />The National Pharmacovigilance Centre (NPC):<br />&bull; Fax: +966-11-205-7662<br />&bull; SFDA Call Center: 19999<br />&bull; E-mail: npc.drug@sfda.gov.sa<br />&bull; Website: https://ade.sfda.gov.sa<br />- Other GCC States:<br />Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Symptoms and Signs<br />A wide margin of safety is evident from available overdose information on paroxetine.<br />Experience of paroxetine in overdose has indicated that, in addition to those symptoms mentioned<br />under &quot;Undesirable effects&quot;, fever and involuntary muscle contractions have been reported.<br />Patients have generally recovered without serious sequelae even when doses of up to 2000 mg<br />have been taken alone. Events such as coma or ECG changes have occasionally been reported and,<br />very rarely with a fatal outcome, but generally when paroxetine was taken in conjunction with<br />other psychotropic drugs, with or without alcohol.<br />Treatment<br />No specific antidote is known.<br />The treatment should consist of those general measures employed in the management of overdose<br />with any antidepressant. Administration of 20-30 g activated charcoal may be considered if<br />possible within a few hours after overdose intake to decrease absorption of paroxetine. Supportive<br />care with frequent monitoring of vital signs and careful observation is indicated. Patient<br />management should be as clinically indicated.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Antidepressants &ndash; selective serotonin reuptake inhibitors, ATC code:<br />N06A B05<br />Mechanism of Action<br />Paroxetine is a potent and selective inhibitor of 5-hydroxytryptamine (5-HT, serotonin) uptake and<br />its antidepressant action and effectiveness in the treatment of OCD, Social Anxiety disorder/Social<br />Phobia, General Anxiety Disorder, Post-Traumatic Stress Disorder and Panic Disorder is thought<br />to be related to its specific inhibition of 5-HT uptake in brain neurones.<br />Paroxetine is chemically unrelated to the tricyclic, tetracyclic and other available antidepressants.<br />Paroxetine has low affinity for muscarinic cholinergic receptors.<br />In accordance with this selective action, in contrast to tricyclic antidepressants, paroxetine has<br />little affinity for alpha1, alpha2 and beta-adrenoceptors, dopamine (D2), 5-HT1 like, 5-HT2 and<br />histamine (H1) receptors. This lack of interaction with post-synaptic receptors lack of CNS<br />depressant and hypotensive properties.<br />Pharmacodynamic Effects<br />Paroxetine does not impair psychomotor function and does not potentiate the depressant effects of<br />ethanol.<br />As with other selective 5-HT uptake inhibitors, paroxetine causes symptoms of excessive 5-HT<br />receptor stimulation when administered to animals previously given monoamine oxidase (MAO)<br />inhibitors or tryptophan.<br />Paroxetine is weakly activating at doses generally above those required to inhibit 5-HT uptake.<br />The activating properties are not &quot;amphetamine-like&quot; in nature.<br />Paroxetine produces no clinically significant changes in blood pressure, heart rate and ECG after<br />administration to healthy subjects.</p><p>In contrast to antidepressants which inhibit the uptake of noradrenaline, paroxetine has a much<br />reduced propensity to inhibit the antihypertensive effects of guanethidine.<br />In the treatment of depressive disorders, paroxetine exhibits comparable efficacy to standard<br />antidepressants.<br />There is also some evidence that paroxetine may be of therapeutic value in patients who have<br />failed to respond to standard therapy.<br />Morning dosing with paroxetine does not have any detrimental effect on either the quality or<br />duration of sleep. Moreover, patients are likely to experience improved sleep as they respond to<br />paroxetine therapy.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption<br />Paroxetine is well absorbed after oral dosing and undergoes first-pass metabolism. Due to firstpass<br />metabolism, the amount of paroxetine available to the systemic circulation is less than that<br />absorbed from the gastrointestinal tract. Partial saturation of the first-pass effect and reduced<br />plasma clearance occur as the body burden increases with higher single doses or on multiple<br />dosing. This results in disproportionate increases in plasma concentrations of paroxetine and hence<br />pharmacokinetic parameters are not constant, resulting in non-linear kinetics. However, the nonlinearity<br />is generally small and is confined to those subjects who achieve low plasma levels at low<br />doses.<br />Steady state systemic levels are attained by 7 to 14 days after starting treatment with immediate or<br />controlled release formulations and pharmacokinetics do not appear to change during long-term<br />therapy.<br />Distribution<br />Paroxetine is extensively distributed into tissues and pharmacokinetic calculations indicate that<br />only 1% of the paroxetine in the body resides in the plasma.<br />Approximately 95% of the paroxetine present is protein bound at therapeutic concentrations.<br />No correlation has been found between paroxetine plasma concentrations and clinical effect<br />(adverse experiences and efficacy).<br />Biotransformation<br />The principal metabolites of paroxetine are polar and conjugated products of oxidation and<br />methylation which are readily cleared. In view of their relative lack of pharmacological activity, it<br />is most unlikely that they contribute to paroxetine&#39;s therapeutic effects.<br />Metabolism does not compromise paroxetine&#39;s selective action on neuronal 5-HT uptake.<br />Elimination<br />Urinary excretion of unchanged paroxetine is generally less than 2% of dose whilst that of<br />metabolites is about 64% of dose. About 36% of the dose is excreted in faeces, probably via the<br />bile, of which unchanged paroxetine represents less than 1% of the dose. Thus paroxetine is<br />eliminated almost entirely by metabolism.<br />Metabolite excretion is biphasic, being initially a result of first-pass metabolism and subsequently<br />controlled by systemic elimination of paroxetine.<br />The elimination half-life is variable but is generally about one day.<br />Special Patient Populations<br />Older people and Renal/Hepatic Impairment Increased plasma concentrations of paroxetine occur<br />in elderly subjects and in those subjects with severe renal impairment or in those with hepatic<br />impairment, but the range of plasma concentrations overlaps that of healthy adult subjects.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Calcium hydrogen phosphate,<br />Sodium Starch Glycolate,<br />Magnesium stearate &amp;<br />Opadry White OY-L-28900.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C, in a dry place.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>PADO&reg; 20 is packed in white opaque PVC/ PVDC/ Aluminum foil blister, in carton box<br />with a multi folded leaflet.<br />&minus; Pack size: PADO&reg; 20 is available in the pack size of 30 F.C. tablets (10 tablets/blister, 3<br />blisters/ pack).<br />Hospital packs are also available.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused product or waste should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                United Pharmaceutical Company
Tel: 00962 6 4162901
Fax: 00962 6 4162905
E-mail: info@upm.com.jo
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Nov, 2020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>